Details of the Drug

General Information of Drug (ID: DM49DUI)

Drug Name
Tretinoin
Synonyms
Retinoic acid; tretinoin; 302-79-4; Vitamin A acid; all-trans-Retinoic acid; trans-Retinoic acid; ATRA; Airol; Retin-A; Vesanoid; Renova; Dermairol; Aknoten; Eudyna; Aberel; all-trans-Vitamin A acid; Aknefug; All-trans Retinoic Acid; Cordes vas; Epi-aberel; Atralin; Vitamin A1 acid, all-trans-; Tretin M; Retin-A Micro; all-trans-Vitamin A1 acid; Vitamin A acid, all-trans-; all-trans-Tretinoin; Effederm; Retionic acid; TRETINON; Retinoic acid, all-trans-; Alltrans-retinoic acid; beta-Ra; all-(E)-Retinoic acid; beta-Retinoic acid; Avitoin; Aberela; Acnavit; Atragen; Betarretin; Lsotretinoin; Nexret; Panretyn; REA; Retacnyl; Retinoate; Retinova; Solage; Tretinoina; Tretinoine; Tretinoino; Tretinoinum; Vesnaroid; Vitinoin; Aberela [Norway]; Accutane Roche; Acnavit [Denmark]; All Trans Retinoic Acid; Avita Gel; Avitoin [Norway]; Beta all trans Retinoic Acid; Cordes VAS [Germany]; Effederm [France]; Panretin Gel; Retin A; Trans Retinoic Acid; Tretinoin Potassium Salt; Tretinoin Sodium Salt; Tretinoin Zinc Salt; Tretinoin liposome; AGN100335; AGN 192013; ALRT 1057; BAL4079; LGD 100057; R 2625; [3H]Retinoic acid; A-Vitaminsyre; A-Vitaminsyre [Denmark]; AT-RA; Aberela (TN); Acid, Retinoic; Acid, Vitamin A; All trans-Retinoic acid; Atra-IV; Avita (TN); B-Retinoic acid; BML2-E05; Beta-Ra; Beta-Retinoic acid; Potassium Salt, Tretinoin; RETINOIC ACID, ALL TRANS; Renova (TN); Retin A (TN); Retisol-A; Ro 1-5488; Salt, Tretinoin Potassium; Salt, Tretinoin Sodium; Salt, Tretinoin Zinc; Sodium Salt, Tretinoin; Stieva-A; Stieva-a Forte; Trans-Retinoicacid; Tretinoin (TN); Tretinoina [INN-Spanish]; Tretinoine [INN-French]; Tretinoino [INN-Spanish]; Tretinoinum [INN-Latin]; Tri-Luma; Vesanoid (TN); Zinc Salt, Tretinoin; A-Acido (Argentina); Acid A Vit (Belgium, Netherlands); Acid, trans-Retinoic; Acide retinoique (French) (DSL); All-trans-Retinoic acid; All-trans-Tretinoin; All-trans-Vitamin A acid; All-trans-Vitamin A1 acid; PDT-002-002; Retin-A (TN); Stieva-A (TN); Tretinoin 01% cream or placebo; Tretinoin [USAN:INN:BAN]; Tretinoin/All-Trans Retinoic Acid; Tretinoine (French) (EINECS); Acid, all-trans-Retinoic; All-(E)-Retinoic acid; All-trans-b-Retinoic acid; All-trans-beta-Retinoic acid; Beta-all-trans-Retinoic acid; Tretinoin (JAN/USP/INN); Acid, beta-all-trans-Retinoic; Retinoic acid, all-trans-(8CI); Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin; 15-Apo-beta-caroten-15-oic acid; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; 9(Z)-Retinoic acid; 9-cis-RA; 9-trans-retinoic acid
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [1]
Acute myelogenous leukaemia 2A41 Approved [2]
Acute promyelocytic leukaemia 2A60.0 Approved [3]
Melasma ED60.1 Approved [2]
Neuroblastoma 2D11.2 Investigative [2]
Therapeutic Class
Keratolytic Agents
ATC Code
D10AD01: Tretinoin
D10AD: Retinoids for topical use in acne
D10A: ANTI-ACNE PREPARATIONS FOR TOPICAL USE
D10: ANTI-ACNE PREPARATIONS
D: DERMATOLOGICALS
L01XF01: Tretinoin
L01XF: Retinoids for cancer treatment
L01X: OTHER ANTINEOPLASTIC AGENTS
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 300.4
Logarithm of the Partition Coefficient (xlogp) 6.3
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
ADMET Property
BDDCS Class
Biopharmaceutics Drug Disposition Classification System (BDDCS) Class 2: low solubility and high permeability [4]
Elimination
0.5% of drug is excreted from urine in the unchanged form [4]
Half-life
The concentration or amount of drug in body reduced by one-half in 0.5 - 2 hours [5]
Metabolism
The drug is metabolized via the hepatic []
MRTD
The Maximum Recommended Therapeutic Dose (MRTD) of drug that ensured maximising efficacy and moderate side effect is 3.70165 micromolar/kg/day [6]
Chemical Identifiers
Formula
C20H28O2
IUPAC Name
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
Canonical SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
InChI
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+
InChIKey
SHGAZHPCJJPHSC-YCNIQYBTSA-N
Cross-matching ID
PubChem CID
444795
ChEBI ID
CHEBI:15367
CAS Number
302-79-4
UNII
QGJ09HO5S0
DrugBank ID
DB17418
TTD ID
D02DGU
VARIDT ID
DR00154
INTEDE ID
DR1634
ACDINA ID
D00699
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Retinoic acid receptor (RAR) TTOD7B3 NOUNIPROTAC Binder [7]
Retinoic acid receptor gamma (RARG) TT1Q3IE RARG_HUMAN Agonist [8]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [9]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Substrate [10]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Substrate [11]
Cytochrome P450 2A6 (CYP2A6) DEJVYAZ CP2A6_HUMAN Substrate [11]
Cytochrome P450 3A5 (CYP3A5) DEIBDNY CP3A5_HUMAN Substrate [10]
Cytochrome P450 2B6 (CYP2B6) DEPKLMQ CP2B6_HUMAN Substrate [11]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Substrate [10]
Cytochrome P450 3A7 (CYP3A7) DERD86B CP3A7_HUMAN Substrate [10]
Cytochrome P450 2C18 (CYP2C18) DEZMWRE CP2CI_HUMAN Substrate [10]
Cytochrome P450 26C1 (CYP26C1) DEXNDR0 CP26C_HUMAN Substrate [12]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
(E2-independent) E3 ubiquitin-conjugating enzyme FATS (C10ORF90) OT6DNZC4 CJ090_HUMAN Gene/Protein Processing [13]
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1) OTG2T749 CP24A_HUMAN Gene/Protein Processing [14]
1,4-alpha-glucan-branching enzyme (GBE1) OTK2N05B GLGB_HUMAN Gene/Protein Processing [13]
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (AGPAT4) OT5CTQKO PLCD_HUMAN Gene/Protein Processing [13]
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (AGPAT5) OTNY3VMD PLCE_HUMAN Gene/Protein Processing [13]
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3) OTAUR5TG PLCC_HUMAN Gene/Protein Processing [15]
1-phosphatidylinositol 3-phosphate 5-kinase (PIKFYVE) OTO3HGAA FYV1_HUMAN Gene/Protein Processing [16]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (PLCB1) OT9HYT7A PLCB1_HUMAN Gene/Protein Processing [17]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (PLCB2) OTPAHDGO PLCB2_HUMAN Gene/Protein Processing [13]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (PLCE1) OTJISZOX PLCE1_HUMAN Gene/Protein Processing [15]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Acne vulgaris
ICD Disease Classification ED80
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Retinoic acid receptor gamma (RARG) DTT RARG 5.43E-04 -0.14 -0.37
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

Experimental Cancer Drug Sensitivity Information

Cancer Drug Sensitivity Data Curated from 45 Cell Line(s) in Bone Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
RPMI-3460/CS1 GDSC1 6.4323 8.31 2.7184 0.2769
TC-71 GDSC1 3.6198 5.1671 2.6343 4.4354
EW-1 GDSC1 4.393 6.2846 2.6093 2.7248
HuO9 GDSC1 4.5152 15.054 -1.5818 26.335
ES7 GDSC1 4.7236 12.4803 -0.1481 19.7164
EW-22 GDSC1 4.7318 6.9785 2.4919 2.8703
Hs 888.T CTRP2 4.7814 17.6629 -0.2642 31.1365
CADO-ES1 GDSC1 4.8746 7.6107 2.2916 3.9251
G-292 clone A141B1 GDSC1; CTRP2 4.9413 18.1493 -0.3581 30.9576
HuO-3N1 GDSC1 5.0598 23.5026 -5.3592 33.8185
NOS-1 [Human HNSCC] GDSC1 5.0716 13.8792 -0.579 20.761
SK-N-MC CTRP2 5.0858 12.6012 2.4909 22.7329
EW-7 GDSC1 5.1459 14.7389 -0.947 22.1426
CHSA8926 GDSC1 5.1804 7.1516 2.6453 1.3304
ES8 GDSC1 5.2209 7.3003 2.6044 1.4919
ES1 GDSC1 5.2341 7.5855 2.4941 2.0705
U-CH2 GDSC2 5.3678 7.3503 2.6509 0.8924
CAL-72 GDSC1 5.4277 17.626 -2.16 25.7635
EW-12 GDSC2 5.4584 7.5484 2.6136 0.96
EW-24 GDSC1 5.4589 7.0706 2.7939 0.4847
ES5 GDSC1; GDSC2 5.492 7.8363 2.5148 1.3163
CAL-78 GDSC1 5.5718 7.0874 2.8308 0.3241
HOS GDSC1; CTRP2 5.5809 6.0562 5.5803 9.6424
EW-11 GDSC1 5.6233 16.4632 -1.4434 22.8195
EW-16 GDSC1 5.7753 11.3736 1.1107 9.7771
SK-PN-DW GDSC1 5.859 7.9479 2.6306 0.7965
CHSA0011 GDSC1; GDSC2 5.9646 15.8015 -0.8762 17.1989
ES6 GDSC1 6.0376 13.7928 0.1401 14.7257
EW-3 GDSC1 6.1023 25.1183 -5.3548 31.6389
H-EMC-SS GDSC1 6.1748 8.1522 2.6794 0.4628
SK-ES-1 GDSC1; CTRP2 6.2678 9.5132 5.1032 9.6886
CHSA0108 GDSC1; GDSC2 6.5248 18.6311 -1.8555 19.7097
NY GDSC1 6.6496 14.9202 0.006 14.0049
ES4 GDSC1 6.6952 14.2718 0.3378 12.1928
EW-18 GDSC1 6.7354 20.6208 -2.6741 24.2502
A-673 GDSC1; CTRP2 6.7589 15.2069 2.7086 18.1619
EW-13 GDSC1 6.8669 23.9202 -4.193 27.8361
Hs 822.T CTRP2 7.2663 8.4174 6.5163 1.7067
SJSA-1 GDSC1; CTRP2 7.7581 12.8126 4.7153 8.3825
SW1353 CTRP2 7.9963 9.2497 5.6397 0.1312
TC71 CTRP2 8.1825 9.2406 6.6674 0.2772
U2OS GDSC1; GDSC2; CTRP2; CTRP1 8.8804 11.1149 6.2725 1.0465
MHH-ES-1 GDSC1; GDSC2; CTRP2 9.4503 16.5279 4.109 8.2108
MG-63 GDSC1; CTRP2 10.8922 29.6712 -1.2612 22.1383
SaOS-2 GDSC1; CTRP2 10.9445 22.8043 2.1123 13.1608
⏷ Show the Full List of 45 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 218 Cell Line(s) in Haematopoietic And Lymphoid Tissue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
JK1 CTRP2 4.8518 9.9584 3.5039 19.6049
MEC1 CTRP2 8.4535 18.4224 1.7302 14.1496
JM1 GDSC1; GDSC2; CTRP2 2.394 10.2504 0.8314 35.4488
EoL-1 GDSC1; CTRP2 -11.9799 0.2077 -12.3294 86.5974
SIG-M5 GDSC2; CTRP2 -6.959 -1.0809 -7.0001 83.09
ATN-1 GDSC1 -6.7613 4.3516 -7.9797 75.9397
OCI-AML-3 GDSC1; CTRP2; CTRP1 -5.956 7.2401 -7.1945 69.4469
MV4-11 GDSC1; CTRP2 -4.4535 3.1464 -4.6955 70.3575
Karpas-231 GDSC1 -4.3583 -0.0731 -4.4329 81.4923
SK-MM-2 GDSC1; CTRP2 -2.7273 7.5612 -3.7697 59.9719
HuT 78 CTRP2 -2.2132 5.1298 -2.6102 59.4194
MOLM-13 GDSC1; CTRP2 -0.3277 4.1395 -0.4343 49.1976
HH [Human lymphoma] GDSC1; CTRP2 -0.1685 21.9067 -7.0196 49.321
NCI-H929 GDSC1; CTRP2 0.2031 12.202 -2.2732 47.3902
MOLT-13 GDSC1 0.2699 27.9774 -11.6333 48.137
ALL-PO GDSC1 0.4245 13.3721 -4.2834 45.5056
NOMO-1 GDSC1; CTRP1 0.4786 14.7171 -3.0527 52.5705
SKM-1 GDSC1; GDSC2; CTRP1 0.4806 10.8357 -1.4153 48.7638
EM-2 GDSC1; CTRP2 0.948 12.1706 -1.4809 44.1699
M-07e CTRP2 1.4551 13.1468 -1.3763 42.3159
HL-60 GDSC1; CTRP2 1.4703 25.8953 -7.9103 44.7633
NKM-1 GDSC1 1.8349 20.437 -6.5043 42.7645
KMS-34 CTRP2 1.9977 7.4666 1.4114 35.3745
KMS-28BM CTRP2 2.0687 16.426 -2.2518 41.3586
BV-173 GDSC1 2.2859 17.8818 -4.8384 39.9628
Pfeiffer CTRP2 2.3526 11.3631 0.3228 36.7015
NU-DUL-1 GDSC1; GDSC2; CTRP2; CTRP1 2.3997 5.7356 2.2647 31.5329
SEM CTRP2 2.4912 9.2082 1.3463 33.8233
JVM-3 GDSC1; CTRP2 2.5005 16.6915 -1.9538 39.8197
KMS-12-BM GDSC1; CTRP2 2.5866 5.6741 2.4718 30.0519
Loucy GDSC1 2.6182 10.8184 -1.0278 30.7647
PL21 CTRP1 2.7053 8.0041 2.0196 57.517
Mino CTRP2 2.7727 14.5841 -0.6979 37.2662
Mono-Mac-6 GDSC1; CTRP2 2.8104 12.209 0.4237 35.0156
TUR GDSC1 2.8682 13.3981 -2.0991 33.1514
OCI-Ly7 GDSC1; GDSC2 2.8723 6.2225 1.4818 12.9977
Ri-1 CTRP2 3.0193 11.7302 0.8494 33.3846
DoHH2 GDSC1; GDSC2; CTRP2 3.437 7.7818 2.5896 21.9677
JVM-2 GDSC1 3.4701 28.2074 -8.9976 40.9832
SUP-T1 GDSC1; CTRP2 3.5823 6.3563 3.2662 18.819
NU-DHL-1 CTRP2 3.614 12.7387 0.992 31.2522
L-1236 GDSC1; CTRP2 3.6353 11.1135 1.7515 29.0637
L-363 GDSC1 3.7393 34.4522 -11.8967 42.2162
MEG-01 GDSC1 4.0439 13.2774 -1.0677 25.8821
LC4-1 GDSC1 4.1677 7.099 2.0833 7.0753
GDM-1 GDSC1; CTRP1 4.1947 6.0571 4.1388 24.6446
RPMI-8226 GDSC1; CTRP2; CTRP1 4.2164 11.6969 2.0893 26.5177
SU-DHL-6 GDSC1; CTRP2 4.2934 9.7032 3.0453 26.127
VL51 GDSC1 4.3375 6.4449 2.5037 3.5688
Karpas-1106P GDSC1 4.3834 6.4689 2.5204 3.3542
OCI-AML-2 GDSC1 4.4101 9.556 1.0587 13.676
DG-75 GDSC1 4.4208 7.0551 2.2724 5.0339
Raji GDSC1 4.4639 6.4349 2.5826 2.7672
Mono-Mac-1 CTRP2 4.4848 9.1657 3.4732 20.7096
KG-1 GDSC1 4.4958 16.5727 -2.3524 28.8166
SUP-T11 CTRP2 4.5034 7.998 3.9565 18.8271
P32/ISH GDSC1 4.5336 8.5132 1.6535 9.2239
SUP-B8 GDSC1; GDSC2 4.5427 8.3497 1.7382 6.9569
THP-1 GDSC1; GDSC2; CTRP2; CTRP1 4.5601 9.8358 3.277 21.4278
SU-DHL-5 GDSC1; CTRP1 4.5628 5.681 4.5553 21.2989
BC-1 GDSC1 4.5909 9.1984 1.3622 11.1065
RC-K8 GDSC1 4.5957 7.6548 2.1027 5.8407
TALL-1 [Human adult T-ALL] GDSC2; CTRP2 4.6235 7.4582 4.2737 17.2914
KOPN-8 GDSC1 4.6391 7.5428 2.1821 5.175
MHH-CALL-4 GDSC2; CTRP2 4.6476 7.0263 4.4297 16.6473
MHH-CALL-3 CTRP2 4.6623 9.4531 3.5342 19.9934
ML-2 GDSC1 4.6912 17.5163 -2.6689 29.1618
U-937 CTRP2; CTRP1 4.7023 8.594 3.9506 18.4838
WSU-DLCL2 GDSC1; CTRP2; CTRP1 4.7128 6.723 4.5818 16.1044
MOLT-4 GDSC1 4.7385 7.2484 2.3758 3.6252
U-698-M GDSC1 4.7678 6.9624 2.5186 2.6356
RCH-ACV GDSC1; GDSC2; CTRP2 4.7688 10.1275 3.3436 20.4346
HC-1 GDSC1 4.7848 11.5357 0.3612 16.83
KMOE-2 GDSC1 4.7923 11.4458 0.4107 16.5279
BALL-1 GDSC1 4.8225 13.0015 -0.3313 20.3217
KMS-11 GDSC1; GDSC2; CTRP1 4.8428 7.1555 4.6134 17.0558
MOLM-6 CTRP2 4.8478 14.302 1.4424 26.687
BC-3 GDSC2 4.8904 6.9872 2.5724 1.6921
CTB-1 GDSC1; GDSC2 4.8906 14.8093 -1.1726 20.8196
JSC-1 GDSC1 4.9067 9.8871 1.2477 11.0213
BONNA-12 GDSC2 4.9285 7.5472 2.3503 2.761
SU-DHL-8 CTRP2 4.9308 6.2744 4.8921 14.1197
Jiyoye GDSC1 4.9448 15.4862 -1.4664 24.7082
MHH-PREB-1 GDSC1 4.9854 6.8928 2.6586 1.4896
BE-13 GDSC1 5.0059 29.705 -8.4938 37.7427
YT GDSC1 5.0334 13.0843 -0.2168 19.1628
MOLT-16 GDSC1; CTRP2 5.0575 10.8015 3.3208 19.7743
Farage GDSC1; GDSC2 5.0609 12.1849 0.2428 14.115
OPM-2 GDSC1; CTRP2 5.1007 9.4619 3.9791 17.1064
MHH-CALL-2 GDSC1 5.1181 7.1012 2.6367 1.4452
CRO-AP2 GDSC1; GDSC2 5.1243 6.8054 2.7562 0.6956
Ku812 GDSC1; CTRP2; CTRP1 5.1603 16.3408 0.733 27.8779
NK-92MI GDSC2 5.1832 7.2754 2.5968 1.2655
SR GDSC1 5.1989 6.7126 2.8222 0.5468
CESS GDSC1 5.2025 7.105 2.6738 1.168
IM-9 GDSC1 5.2205 6.475 2.916 0.2522
MY-M12 GDSC1; GDSC2 5.2504 8.7818 1.9824 4.2372
ARH-77 GDSC1 5.291 12.0562 0.4669 14.8239
JURL-MK1 GDSC1; CTRP2 5.3411 21.08 -1.4524 32.1786
KHM-1B CTRP2 5.3549 17.1118 0.5285 27.9428
NCO2 CTRP2 5.3608 16.0258 1.0707 26.4953
KMS-26 CTRP2 5.3724 6.4251 5.3427 11.1355
CTV-1 GDSC1 5.4267 27.3755 -6.999 35.3584
EB1 CTRP2 5.4532 8.8428 4.6137 13.677
DND-41 GDSC1; CTRP2 5.4698 7.4391 5.1983 11.3597
RS4;11 GDSC1; CTRP2 5.4731 7.0699 5.3183 10.9063
PF-382 GDSC1; CTRP2 5.4933 6.3426 5.4788 10.2749
MN-60 GDSC1 5.5018 12.8686 0.2205 15.6362
EB2 GDSC1 5.5357 7.2146 2.7715 0.513
Karpas-299 GDSC1 5.5588 10.1526 1.5418 7.5135
NB4 GDSC1; GDSC2 5.5607 11.9886 0.6824 10.7646
Karpas-45 GDSC1 5.5905 18.479 -2.4591 26.2656
SUP-M2 GDSC1; CTRP2 5.5994 8.7885 4.7868 12.6084
P30/OHK GDSC1 5.6253 12.5833 0.4417 14.1028
A4/Fukuda GDSC1; CTRP2 5.6554 19.951 -1.2356 28.2445
Sc-1 GDSC1 5.6663 7.1946 2.8279 0.2938
TK [Human B-cell lymphoma] GDSC1 5.6739 7.4634 2.735 0.5517
PL-21 GDSC1; GDSC2 5.6824 15.9811 -1.1645 18.96
P12-Ichikawa GDSC1; CTRP2 5.7542 11.9214 3.4496 17.5845
MOLP-8 GDSC1; CTRP2 5.7544 6.8686 5.6773 8.7476
HPB-ALL CTRP2 5.7842 6.9964 5.6781 8.6523
Peer CTRP2 5.8434 15.773 1.6295 23.7466
MOLM-16 GDSC1; GDSC2; CTRP2; CTRP1 5.8519 7.9633 5.4187 9.659
CML-T1 GDSC1; CTRP2 5.8573 13.9068 2.5668 20.6248
WIL2 NS GDSC1 5.8628 7.3968 2.8289 0.2263
VAL GDSC1 5.8833 7.7874 2.699 0.5495
SU-DHL-4 GDSC1; GDSC2; CTRP2; CTRP1 5.8835 7.1859 5.7394 8.3513
Ramos.2G6.4C10 GDSC1 5.9043 23.881 -4.8928 31.2244
Daudi GDSC1; CTRP2 5.9045 6.9914 5.8107 7.8047
Kasumi-1 GDSC1; GDSC2; CTRP2 5.939 6.9247 5.8653 7.502
MOLP-2 CTRP2 5.9866 12.3333 3.461 17.0068
697 GDSC1; CTRP2 6.0186 15.2088 2.0653 21.9675
MLMA GDSC1 6.0431 7.8488 2.7374 0.368
CCRF-CEM GDSC1 6.0645 29.3828 -7.4994 34.7928
H9 GDSC1 6.0711 8.2294 2.6116 0.7256
MOLT-3 CTRP2 6.0917 8.7301 5.3076 9.2666
A3/Kawakami GDSC1; CTRP2 6.1405 7.0799 6.0436 6.24
Reh GDSC1 6.1578 15.104 -0.4061 17.1428
RPMI-8866 GDSC1 6.1915 23.3886 -4.4319 29.7309
OCI-Ly3 CTRP2 6.1933 14.016 2.8127 18.9907
GR-ST GDSC1 6.2077 22.1412 -3.8044 28.3391
KMS-18 CTRP2 6.2088 12.6559 3.5019 16.3524
Granta-519 GDSC1; CTRP2 6.2349 12.3424 3.6807 15.5909
SET-2 CTRP2 6.2406 7.3012 6.0796 5.8115
DEL GDSC1; CTRP2 6.2517 6.9891 6.1902 5.3691
KY821 GDSC1 6.2833 23.4381 -4.3875 29.4478
AML-193 CTRP2 6.3011 6.9386 6.2565 4.9787
HD-MY-Z CTRP2 6.3038 7.3619 6.125 5.4587
Hs 611.T CTRP2 6.4273 14.1131 2.9697 17.9068
SU-DHL-16 GDSC1; GDSC2 6.4446 16.0911 -0.6851 15.4185
KMS-27 CTRP2 6.468 8.4211 5.8204 6.2591
MC116 GDSC1; GDSC2; CTRP2; CTRP1 6.5033 7.1032 6.4319 3.7259
RPMI-6666 GDSC1; CTRP2 6.5577 12.1558 4.0589 13.3774
GA-10 GDSC1; CTRP2 6.5588 19.2288 0.5287 25.3068
KYO-1 CTRP2 6.5627 14.8841 2.7021 18.5945
Jurkat GDSC1; CTRP2 6.5709 12.8538 3.7224 14.705
Toledo CTRP2 6.5757 7.5964 6.3119 3.993
SU-DHL-10 CTRP2 6.6416 7.1012 6.5829 2.7565
QIMR-WIL GDSC1; GDSC2 6.6689 22.8859 -3.8302 25.1402
ST486 GDSC1; CTRP2 6.7236 12.7698 3.896 13.6932
KMS-21-BM CTRP2 6.7386 14.1056 3.2416 16.231
AMO1 GDSC1; CTRP2; CTRP1 6.7421 7.2909 6.6306 2.5264
MOTN-1 CTRP2 6.7468 7.8427 6.3648 3.3593
HAL-01 GDSC1 6.7622 21.0912 -2.8844 24.7957
HDLM-2 GDSC1; CTRP2 6.781 16.6681 1.9969 20.5543
ME1 GDSC1 6.7865 16.5822 -0.6907 16.9755
BL-41 GDSC1; CTRP2 6.863 10.2594 5.2692 7.7113
EJM GDSC1; CTRP2; CTRP1 6.8748 14.5418 3.1629 16.4265
SUP-HD1 GDSC1; CTRP2 7.038 9.0979 5.9976 4.2938
MM1.S GDSC1; CTRP2 7.125 17.3245 1.9566 19.9886
ME1 CTRP2 7.132 17.757 1.0679 18.8095
L-540 GDSC1; CTRP2 7.1936 16.9015 2.2248 18.9659
ROS-50 GDSC1; GDSC2 7.1999 16.104 -0.1988 11.9033
BL-70 CTRP2; CTRP1 7.2375 9.8143 5.0367 2.5898
P3HR-1 CTRP2; CTRP1 7.2665 9.1231 6.1679 3.1596
RL GDSC1; GDSC2; CTRP2 7.2716 15.696 2.8915 16.4719
WSU-NHL GDSC1 7.3257 16.9897 -0.533 15.1165
HEL 92.1.7 CTRP2 7.4392 12.655 3.817 7.4802
TF-1 CTRP2 7.506 12.3717 4.0004 6.5872
Ki-JK CTRP2 7.7708 11.7831 4.4545 4.2865
OCI-AML-5 GDSC1; CTRP2 7.8197 32.1156 -4.8661 32.6935
K-562 GDSC1; CTRP2 7.837 9.2836 5.5668 0.2997
REC-1 CTRP2 7.8479 12.1351 5.1171 6.5702
KMS-20 CTRP2 7.8821 14.0629 3.4441 8.36
ALL-SIL GDSC1; CTRP2 7.9965 14.0644 4.2766 9.7723
LAMA-84 GDSC1; CTRP2 8.0047 52.4079 -14.8571 39.7973
KMM-1 CTRP2 8.0216 16.3058 2.4536 12.1542
LP-1 GDSC1; GDSC2; CTRP2; CTRP1 8.1724 16.5142 3.2241 13.7517
P31/FUJ GDSC1; CTRP2 8.2413 24.6368 -0.7908 25.2714
KE-37 GDSC1; CTRP2 8.313 17.5535 2.7899 14.9246
KM-H2 GDSC1; CTRP2 8.3165 20.7614 1.1993 20.0829
KCL-22 GDSC1; CTRP2 8.3604 19.1069 2.0557 17.3542
Karpas-422 GDSC1; CTRP2 8.3762 10.0064 6.4505 0.7419
KE-97 CTRP2; CTRP1 8.6643 11.2654 6.0625 1.7656
NALM-6 GDSC1; CTRP2 8.8497 21.5783 1.2055 19.142
MJ CTRP2 8.881 12.9516 5.4264 3.8691
CA46 GDSC1; CTRP2 8.8822 16.1276 3.9112 9.7982
OCI-Ly19 GDSC1; GDSC2; CTRP2 8.906 10.8807 6.3458 0.6971
Karpas-620 GDSC1; CTRP2 8.9157 10.2888 6.5743 0.1973
JJN-3 GDSC1; CTRP2 9.0432 17.2518 2.6996 9.6157
OCI-M1 GDSC1; CTRP2 9.0936 17.4399 2.6435 9.7584
CMK GDSC1; CTRP2 9.1588 20.1902 2.123 15.7858
DB GDSC1; CTRP2 9.2846 10.9648 6.4727 0.2588
KO52 CTRP2 9.4601 37.317 -6.8445 30.9729
EHEB GDSC1; CTRP2 9.4832 28.4853 -2.455 24.0511
JeKo-1 GDSC1; GDSC2; CTRP2 9.4866 19.7264 2.5886 13.7065
SUP-B15 GDSC1; CTRP2 9.5193 13.5474 5.5307 2.7952
Namalwa GDSC1; CTRP2 9.6859 21.3113 1.9578 15.4845
OCI-Ly10 CTRP2; CTRP1 9.6939 18.8957 3.1666 11.5244
Ci-1 CTRP2 9.7592 29.3157 -1.9337 25.1639
RPMI-8402 GDSC1; CTRP2 10.6577 19.1147 3.6706 8.251
SU-DHL-1 GDSC2; CTRP2 11.2358 21.4928 2.9248 10.1174
HT GDSC1; GDSC2; CTRP2; CTRP1 11.3244 20.2131 3.5741 7.7935
Kasumi-2 CTRP2 11.5659 27.4577 -0.484 16.4204
L-428 GDSC1; CTRP2 11.6982 22.8042 2.6047 10.6008
F-36P CTRP2 11.9928 30.8005 -1.0223 20.1112
HEL GDSC1; GDSC2; CTRP2 12.0817 23.9997 2.2885 11.1409
U266B1 GDSC1; CTRP2 12.47 29.405 -0.0189 17.1368
⏷ Show the Full List of 218 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 28 Cell Line(s) in Oesophagus Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
TE8 CTRP2 7.2821 10.5505 5.4698 6.0647
TE15 CTRP2 11.6244 30.2723 -1.0263 20.613
T.T GDSC1 4.8466 11.3181 0.5123 15.7867
KYSE-270 GDSC1 4.9794 6.991 2.6154 1.7336
TE-15 GDSC1 4.9811 8.0418 2.1594 4.6032
TE-8 GDSC1 5.0297 7.2884 2.5161 2.2331
TE-5 GDSC1; CTRP2 6.9987 8.3752 6.3261 2.9839
KYSE-70 GDSC1; CTRP2 7.2937 11.4045 3.4857 3.7849
TE-10 GDSC1; GDSC2; CTRP2 7.5694 9.3665 6.2689 2.2624
KYSE-410 GDSC1; CTRP2; CTRP1 7.8109 11.4135 5.4442 5.2773
OE19 GDSC1; CTRP2 7.8508 9.13 5.6279 0.1831
EC-GI-10 GDSC1; CTRP2 7.8727 15.9802 2.5055 12.2009
TE-1 GDSC1; CTRP2 7.9238 10.2116 6.1018 2.4454
TE-4 GDSC1; CTRP2 7.9941 15.7733 3.428 13.1232
OE33 GDSC1; CTRP2 8.123 10.0233 5.4067 0.5357
TE-11 GDSC1; GDSC2; CTRP2 8.3953 10.2001 5.4519 0.3267
KYSE-150 GDSC1; CTRP2 8.4183 9.7636 5.6137 0.0898
KYSE-520 GDSC1; CTRP2 8.6737 10.5081 5.448 0.2508
TE-6 GDSC1; CTRP2 8.691 16.3036 3.6882 10.9561
COLO 680N GDSC1; CTRP2 8.7198 10.2422 6.5128 0.3836
KYSE-30 CTRP2 9.2069 10.6172 6.5669 0.1404
KYSE-140 GDSC1; CTRP2; CTRP1 9.3215 21.3651 1.6653 16.9792
KYSE-450 GDSC1; CTRP2; CTRP1 9.5437 19.6865 1.873 11.9528
TE-14 CTRP2 10.1788 22.2297 1.8616 15.0418
TE-9 GDSC1; CTRP2 10.4808 17.1975 4.4463 5.6667
OE21 GDSC1; CTRP2 11.0356 30.2993 -2.2172 21.3097
KYSE-510 GDSC1; GDSC2; CTRP2 11.5661 20.0336 3.7999 6.7485
KYSE-180 GDSC1; CTRP2 11.6051 21.5021 3.1517 8.9053
⏷ Show the Full List of 28 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 40 Cell Line(s) in Pancreas Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
N2a-PK1 CTRP2 15.7204 32.4471 -0.2315 11.0859
KP-1N GDSC1 4.8316 7.0718 2.5054 2.611
PL4 GDSC1 5.5445 7.1846 2.7858 0.4633
MZ-PC-1 GDSC1; GDSC2 5.6812 9.6003 1.8626 4.2095
Panc 03.27 GDSC1; CTRP2; CTRP1 5.7153 7.0847 5.5784 9.2241
PaTu 8988t GDSC1; CTRP2 6.2282 7.246 6.0857 5.8244
KP-4 GDSC1; CTRP2 6.5793 7.8628 6.1932 4.4641
PK-59 CTRP2 6.6319 7.6975 6.3221 3.8103
HuP-T3 GDSC1; CTRP2 6.8511 8.6353 5.3436 1.8306
Panc 10.05 GDSC1; CTRP2; CTRP1 6.9575 18.2502 1.3543 22.1957
QGP-1 GDSC1; GDSC2; CTRP2; CTRP1 7.2982 9.2435 5.3293 1.3763
SNU-410 CTRP2 7.3 9.8457 5.8349 4.498
MIA PaCa-2 GDSC1; CTRP2 7.3531 8.6252 6.4771 1.7338
YAPC GDSC1; CTRP2 7.4203 8.6037 5.6505 0.2885
PSN1 GDSC1; CTRP2 7.5598 9.0682 6.4052 1.7282
KP-3 GDSC1; CTRP2; CTRP1 7.603 13.1703 4.4179 9.8783
PaTu 8988s CTRP2 7.6311 9.1005 6.4362 1.5125
Panc 08.13 GDSC1; CTRP2 7.642 10.0136 5.1799 1.5838
SNU-213 CTRP2 7.6589 9.1222 5.5539 0.4043
SU.86.86 GDSC1; CTRP2 8.0971 9.8655 6.3651 1.257
Panc 05.04 CTRP2 8.1322 9.9638 5.4332 0.4684
KP-2 GDSC1; CTRP2 8.3066 9.6903 6.5462 0.5152
HPAF-II GDSC1; CTRP2 8.3739 17.702 2.7629 14.9152
Panc 04.03 GDSC1; CTRP2 8.4049 10.1996 6.3843 0.9228
SUIT-2 GDSC1; CTRP2; CTRP1 8.5034 10.4414 6.3323 1.009
Panc 02.03 GDSC1; CTRP2 8.568 15.1915 4.1433 9.3765
PaTu 8902 GDSC1; CTRP2; CTRP1 8.6841 9.7423 6.681 0.1006
L3.3 CTRP2 8.788 9.8736 6.673 0.0914
HPAC GDSC1; CTRP2; CTRP1 8.9544 10.6439 6.4588 0.4008
AsPC-1 GDSC1; CTRP2 8.9772 14.7676 4.6328 6.8364
Capan-2 GDSC1; CTRP2; CTRP1 8.9858 15.3543 4.3573 7.9056
CFPAC-1 GDSC1; CTRP2; CTRP1 9.0787 10.4396 6.582 0.1471
BxPC-3 GDSC1; CTRP2 9.1716 13.2064 5.4847 3.3172
DAN-G GDSC1; CTRP2 9.217 10.6927 6.5441 0.168
TCC-Pan2 CTRP2 9.2661 18.967 1.208 10.3819
SW1990 GDSC1; CTRP2 9.36 10.951 6.5063 0.1881
Capan-1 GDSC1; CTRP2 9.5024 10.8716 6.5846 0.0772
Hs 766T GDSC1; CTRP2 10.1988 18.198 3.8081 8.3347
PK-45H CTRP2 11.3434 24.698 0.6775 13.4077
HuP-T4 GDSC1; CTRP2; CTRP1 11.5137 25.3333 1.2854 14.8945
⏷ Show the Full List of 40 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 77 Cell Line(s) in Skin Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SH4 CTRP2 11.6213 28.3797 -0.1089 18.4763
IST-MEL1 GDSC1 3.9166 5.5197 2.6703 3.3421
CHL-1 GDSC1 3.9737 19.1368 -4.0491 34.154
G-mel GDSC1; GDSC2 3.9842 6.8322 2.0834 6.1093
GAK GDSC1 4.1433 6.1484 2.5205 3.8904
SH-4 GDSC1 4.2672 6.3513 2.5038 3.7245
WM1552C GDSC1 4.5559 8.5292 1.6611 9.1102
M14 GDSC1 4.6442 6.7241 2.5554 2.6146
MZ-MEL-2 GDSC1; GDSC2 4.6604 7.8074 2.0724 4.7561
451Lu GDSC1; GDSC2 4.8066 6.7152 2.6445 1.4505
MMAc-SF GDSC1; GDSC2 4.864 7.2373 2.4509 2.3304
COLO 783 GDSC1; GDSC2 5.0287 6.206 2.9396 0.2179
VMRC-MELG GDSC1; GDSC2 5.0867 6.6125 2.8138 0.5283
WM278 GDSC1 5.1218 7.6351 2.4163 2.691
Hs 938.T GDSC1; GDSC2 5.1983 9.2116 1.7551 5.581
COLO 679 GDSC1 5.2526 6.9284 2.7636 0.7296
CP66-MEL GDSC1; GDSC2 5.258 6.4027 2.9545 0.1257
LB373-MEL-D GDSC1; GDSC2 5.431 6.6936 2.9163 0.1451
MZ-MEL-7 GDSC1; GDSC2 5.4353 6.8929 2.8485 0.2697
A-388 GDSC1; GDSC2 5.4899 7.5641 2.6213 0.908
WM35 GDSC1 5.6189 10.4712 1.4318 8.0948
HMV-II GDSC1 5.6476 8.3716 2.3711 2.2052
DJM-1 GDSC1; GDSC2 5.951 13.6619 0.1448 12.6738
A-375 GDSC1; GDSC2; CTRP2; CTRP1 6.1682 8.1719 5.6562 7.8865
WM266-4 CTRP2 6.4532 13.1939 3.4503 16.025
WM115 GDSC1; CTRP2 6.5514 7.0726 6.4938 3.3538
G-361 GDSC1; CTRP2; CTRP1 6.616 12.5285 3.9238 13.8033
HMCB CTRP2 6.7021 7.8875 6.3006 3.7285
COLO 792 GDSC1; CTRP2 6.7642 9.1591 5.7319 5.9668
CP50-MEL-B GDSC1; GDSC2 6.9264 20.2534 -2.3605 20.5784
SK-MEL-5 GDSC1; GDSC2; CTRP2; CTRP1 6.9274 8.3744 6.2886 3.5058
LB2518-MEL GDSC1; GDSC2 6.9894 18.4314 -1.4381 17.3158
SK-MEL-1 GDSC1; CTRP2; CTRP1 7.1547 8.8668 6.2334 3.2937
A-431 GDSC1; GDSC2 7.369 20.6798 -2.2596 19.425
SK-MEL-2 GDSC1; CTRP2 7.4799 9.1194 6.3264 2.1598
LOX-IMVI GDSC1; CTRP2 7.4883 10.0438 5.8802 3.9887
A2058 GDSC1; CTRP2 7.53 9.6216 6.1177 2.9392
Hs 944.T CTRP2; CTRP1 7.5896 10.281 5.8382 3.9991
Hs 940.T GDSC1; GDSC2; CTRP2 7.6124 9.6774 6.1486 2.6882
Hs 294T CTRP2 7.7691 9.3493 6.4067 1.4577
Hs 852.T CTRP2; CTRP1 7.904 9.389 6.468 1.0849
SK-MEL-28 GDSC1; GDSC2; CTRP2; CTRP1 8.0027 9.0557 6.6944 0.4176
SK-MEL-3 GDSC1; GDSC2; CTRP2 8.1219 9.9274 6.3515 1.2804
HT-144 GDSC1; CTRP2 8.2491 9.9894 6.3934 1.0206
MeWo GDSC1; CTRP2 8.2758 13.2034 4.9039 6.7719
Hs 688(A).T CTRP2 8.2763 10.8102 6.0434 2.2406
WT2-iPS GDSC1; GDSC2; CTRP2 8.3921 9.9951 6.4629 0.6944
Mel Ho GDSC1; GDSC2; CTRP2 8.3977 21.6694 0.8111 21.0433
A101D GDSC1; CTRP2 8.4695 10.1133 6.4516 0.6754
IGR-1 GDSC1; CTRP2 8.4927 10.7268 6.2044 1.4381
SK-MEL-31 GDSC1; GDSC2; CTRP2 8.5787 9.9859 6.5509 0.3613
RPMI-7951 GDSC1; CTRP2 8.6313 10.0988 6.53 0.3846
IGR-39 CTRP2 8.6797 9.8882 6.6278 0.1764
SK-MEL-30 GDSC1; GDSC2; CTRP2 8.6852 9.8799 6.6329 0.1669
Hs 934.T CTRP2 8.7046 19.4321 2.1576 16.4253
IPC-298 GDSC1; GDSC2; CTRP2 8.7591 10.3194 6.5 0.3947
Mel JuSo GDSC1; CTRP2 8.8493 10.8184 6.3446 0.7337
IGR-37 GDSC1; CTRP2 8.9233 10.2835 6.5791 0.1877
CJM [Human melanoma] CTRP2 8.9528 10.0171 6.6821 0.0597
WM793 GDSC1; CTRP2 8.968 14.1728 4.9096 5.7622
RVH-421 GDSC1; GDSC2; CTRP2 9.0716 10.2443 6.6467 0.076
UACC-62 GDSC1; CTRP2 9.0846 10.1221 6.6921 0.0398
WM88 CTRP2 9.1678 11.704 6.1357 1.1182
SK-MEL-24 GDSC1; CTRP2 9.1728 10.5085 6.5922 0.1166
UACC-257 GDSC1; CTRP2 9.2086 10.4067 6.6395 0.0656
COLO 829 GDSC1; CTRP2 9.2493 11.1969 6.3728 0.4621
COLO 741 CTRP2; CTRP1 9.2998 15.3673 4.561 6.6771
Malme-3M CTRP2 9.4042 11.8669 6.1805 0.8456
WM1799 CTRP2 9.836 18.2327 3.5531 9.7574
Hs 895.T CTRP2 10.535 18.8743 3.7054 8.2792
MDA-MB-435S CTRP2 10.6919 21.0142 2.7975 11.2538
K029AX CTRP2 10.9596 24.0913 0.7149 13.8001
COLO 800 GDSC1; GDSC2; CTRP2 11.0008 21.3932 2.0019 9.5611
Hs 936.T CTRP2; CTRP1 12.7095 22.5665 3.3221 7.1411
WM983B CTRP2 13.0513 24.8552 2.4885 9.4093
Hs 839.T CTRP2 13.7396 27.9412 1.4897 11.6046
EquiPSC Line K2 GDSC1; GDSC2 6.0469 8.2278 2.6026 0.6199
⏷ Show the Full List of 77 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 11 Cell Line(s) in Aero Dig Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
KYAE-1 GDSC1 3.8724 15.5928 -2.361 30.6363
ESO-51 GDSC1 4.3012 12.3682 -0.4133 22.283
KYSE-50 GDSC1 4.4943 7.6256 2.0512 6.4579
SK-GT-4 GDSC1 4.7365 7.454 2.2818 4.2686
ESO-26 GDSC1 4.9316 10.2743 1.0785 12.0647
KYSE-220 GDSC1 5.7211 16.7119 -1.4941 22.7584
OACM5.1 C GDSC1 5.7225 13.1936 0.215 15.1024
HCE-4 GDSC1; GDSC2 5.7775 12.4729 0.5954 10.778
FLO-1 GDSC1 6.3693 9.3362 2.3171 1.6755
OACP4 C GDSC1 6.374 9.4173 2.2874 1.8074
TE-12 GDSC1; GDSC2 7.5402 17.139 -0.4675 12.4709
⏷ Show the Full List of 11 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Ascites Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
COLO 684 GDSC1; CTRP2 7.0759 15.4331 2.8615 16.9659
Cancer Drug Sensitivity Data Curated from 34 Cell Line(s) in Autonomic Ganglia Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SK-N-DZ GDSC1; CTRP2 -2.2406 8.8347 -3.6338 57.4819
SJNB-13 GDSC1 -2.0945 2.2192 -2.3288 63.3821
SK-N-MC-IXC GDSC1; GDSC2 -1.5587 7.7772 -3.6454 49.4609
KP-N-YS GDSC1; GDSC2 1.9402 5.1526 1.0994 18.642
TGW GDSC1 2.3408 10.5651 -1.1466 32.2891
SJNB-7 GDSC1 2.9883 5.4757 1.9558 12.0302
SJNB-14 GDSC1 3.8507 11.0293 -0.1004 22.2397
Kelly GDSC1; CTRP2 3.8959 10.5374 2.2726 26.6576
SJNB-6 GDSC1; GDSC2 4.1255 6.7202 2.2369 4.8539
SK-N-BE(2)-M17 GDSC1 4.2655 6.5979 2.3877 4.5668
SJNB-10 GDSC1 4.2886 9.6647 0.9157 14.9771
NB1 GDSC1 4.3029 6.314 2.5429 3.3682
MHH-NB-11 GDSC1; GDSC2 4.434 7.1446 2.2388 4.2167
IMR-5 GDSC1 4.5484 8.5488 1.6465 9.2338
SJNB-5 GDSC1; GDSC2 4.7026 12.7005 -0.2724 17.4617
GI-ME-N GDSC1 4.758 22.827 -5.2612 34.3277
GOTO GDSC1 4.964 14.6201 -1.0239 22.962
LA-N-6 GDSC1; GDSC2 4.9938 6.7569 2.7173 0.9448
CHP-126 GDSC1; GDSC2; CTRP2 5.4367 8.8007 4.6153 13.7139
NH-12 GDSC1 5.5371 7.4746 2.6757 0.8593
NB(TU)1 GDSC1 5.6892 14.212 -0.2987 17.7975
KP-N-RT-BM-1 GDSC2 5.703 7.8002 2.6218 0.7594
SJNB-17 GDSC1; GDSC2 6.1426 8.2756 2.6229 0.5189
SJNB-12 GDSC1 6.1897 8.2179 2.6617 0.505
IMR-32 CTRP2 6.5015 11.9083 3.4842 10.5957
SK-N-BE(2) CTRP2 6.872 18.198 1.3088 22.5034
SK-N-SH GDSC1; CTRP2 7.2288 8.8844 6.2573 2.8499
SK-N-FI GDSC1; CTRP2 7.553 9.282 5.4431 0.7724
NB69 GDSC1 7.8874 21.6601 -2.3781 20.9586
KP-N-YN GDSC1; CTRP2 8.0706 16.2056 3.2724 13.5786
SiMa GDSC1; CTRP2 8.7328 12.1179 5.7195 2.9343
CHP-212 GDSC1; CTRP2 9.1321 52.8005 -14.1332 38.3002
NH-6 CTRP2 9.9017 27.7256 -1.7737 21.9499
SK-N-AS GDSC1; CTRP2 11.1908 22.1506 2.5862 11.3011
⏷ Show the Full List of 34 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 7 Cell Line(s) in Biliary Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SNU-478 CTRP2 6.8902 8.2988 6.2709 3.4365
SNU-1079 CTRP2 8.4679 29.0122 -2.7923 28.7125
HuCC-T1 GDSC1; CTRP2 8.4681 11.0791 6.0345 2.0621
HuH-28 CTRP2 8.8749 10.3039 6.553 0.245
SNU-869 CTRP2 9.0662 11.3294 6.2399 0.8874
SNU-308 CTRP2 11.4294 23.2556 2.2192 12.1765
SNU-1196 CTRP2 16.2582 35.1909 -0.3118 13.5892
⏷ Show the Full List of 7 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 91 Cell Line(s) in Breast Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MDA-MB-157 GDSC1 3.2238 8.8478 0.4768 21.3689
Evsa-T GDSC1 4.2149 7.9391 1.7086 9.7198
MDA-MB-175-VII GDSC1 4.2772 5.8127 2.7537 1.9832
BT-483 GDSC1 4.4883 9.9519 0.9217 14.3322
MDA-MB-415 GDSC1 4.6731 7.1617 2.3769 3.747
UACC-893 GDSC1; GDSC2 4.6798 11.088 0.5041 13.6629
HCC2157 GDSC1 5.0005 22.3425 -4.8282 33.0694
MRK-nu-1 GDSC1 5.0251 6.8786 2.683 1.3144
COLO 824 GDSC1 5.2842 8.2708 2.2281 3.5895
MDA-MB-330 GDSC1; GDSC2 5.543 18.353 -2.4324 23.6421
HCC1599 GDSC2 5.6466 7.5709 2.6846 0.5975
HCC70 GDSC1 5.6693 13.6177 -0.0253 16.4944
OCUB-M GDSC1 5.6766 14.9224 -0.6524 19.4659
HCC1187 GDSC1 5.7444 7.5134 2.7442 0.4848
DU4475 GDSC1; CTRP2 5.9803 6.7086 5.9529 7.0629
MDA-MB-436 GDSC1 6.0832 7.8263 2.7599 0.3006
CAL-148 CTRP2 6.2593 10.0007 4.8577 10.7259
MFM-223 GDSC1 6.2717 13.3142 0.518 12.1403
AU565 GDSC1; CTRP2 6.3812 16.8643 1.5573 22.7823
YMB-1-E GDSC2 6.3842 8.6993 2.5632 0.5628
EFM-19 GDSC1 6.5142 15.0114 -0.1245 14.957
MDA-MB-453 GDSC1; CTRP2 6.8059 9.2403 5.7282 5.8955
UACC-812 CTRP2 6.8322 14.7326 2.3381 14.7496
HCC1143 GDSC1; CTRP2 6.879 9.1014 5.8611 5.185
CAMA-1 GDSC1; CTRP2 6.9854 9.063 5.2286 2.1284
HCC202 GDSC1; CTRP2 7.0094 10.0781 4.7641 4.0593
HCC1569 GDSC1; GDSC2; CTRP2 7.2049 15.2846 3.0424 16.0455
CAL-51 GDSC1; CTRP2 7.2211 8.7439 6.3211 2.5955
MCF-7 GDSC1; CTRP2; CTRP1 7.3251 16.7231 2.4467 18.1103
SK-BR-3 CTRP2 7.5066 19.1439 1.3602 21.0995
CAL-85-1 GDSC1; CTRP2 7.6467 9.8772 6.0758 2.9341
Hs 578Bst CTRP2 7.6734 9.7592 6.1512 2.5897
JIMT-1 GDSC1; CTRP2 7.813 10.0728 6.0951 2.6199
HCC1395 GDSC1; CTRP2 7.8318 11.0167 5.6529 4.3858
KPL-1 CTRP2 7.9137 9.0631 6.6142 0.5849
MDA-MB-468 GDSC1; CTRP2 8.2063 11.3173 5.7633 3.4088
HCC1428 GDSC1; CTRP2 8.2218 24.3072 -1.3419 23.626
HCC1937 GDSC1; CTRP2 8.2615 11.0957 5.9025 2.7949
ZR-75-1 CTRP2 8.2621 15.7444 2.8951 10.0165
BT-549 GDSC1; CTRP2 8.3012 9.9436 5.5082 0.2551
HCC1954 GDSC1; CTRP2 8.4368 15.9658 3.6677 11.447
CAL-120 GDSC1; CTRP2 8.4388 9.799 6.5626 0.4001
HCC1419 GDSC1; CTRP2 8.5525 10.2216 6.4468 0.6362
BT-20 GDSC1; CTRP2 8.7718 15.6098 4.0849 9.2911
HCC38 GDSC1; CTRP2 8.8022 10.6816 5.4347 0.2388
MDA-MB-231 GDSC1; CTRP2 8.8076 17.4575 3.2075 12.5786
BT-474 GDSC1; CTRP2 8.918 10.1702 6.6172 0.1345
HCC1500 GDSC1; CTRP2 9.0818 28.6169 -2.1102 26.5413
HMC-1-8 CTRP2 9.1187 10.0382 6.7309 0.0186
HCC1806 GDSC1; CTRP2 9.3311 12.2654 5.9831 1.4593
HCC2218 GDSC1; GDSC2; CTRP2 9.407 17.042 3.8336 9.3185
HDQ-P1 GDSC1; CTRP2 9.5239 11.1472 6.4979 0.1645
Hs 578T GDSC1; CTRP2 10.3898 33.2366 -3.395 26.8285
ZR-75-30 GDSC1; CTRP2 10.817 20.2105 3.2589 9.5031
T-47D GDSC1; CTRP2 11.0029 20.9817 2.1919 8.9058
MDA-MB-361 GDSC1; CTRP2 12.2866 26.8462 1.0796 14.4735
EFM-192A GDSC1; CTRP2 12.6229 31.0435 -0.702 18.5731
BT 428 CTRP2 5.3406 10.8202 3.5884 18.0339
BT 330 CTRP2 6.828 7.5565 6.58 2.2807
BT 248 CTRP2 6.941 8.493 6.2182 3.5541
BT 416 CTRP2 6.9732 9.372 5.8063 5.2274
BT 131 CTRP2 7.0324 8.2034 6.4402 2.4373
BT 271 CTRP2 7.0734 8.2231 6.464 2.2589
BT164 CTRP2 7.3721 9.0008 5.4713 0.818
BT 482 CTRP2 7.4471 17.3123 2.227 18.4645
BT 172 CTRP2 7.457 11.7355 5.0175 7.6496
BT 333 CTRP2 7.5556 10.9466 5.485 5.5241
BT 422 CTRP2 7.7255 8.9979 6.5408 1.0069
BT 239 CTRP2 7.786 16.2051 3.0508 14.9154
BT 245 CTRP2 7.938 10.2601 6.0882 2.4805
BT147 CTRP2 8.0733 9.6771 6.4347 1.0382
BT 340 CTRP2 8.164 9.2863 6.6417 0.3471
BT 232 CTRP2 8.4555 9.9717 6.5021 0.545
BT 320 CTRP2 8.5261 9.4214 6.7349 0.0672
BT 498 CTRP2 8.6468 9.8026 6.6459 0.1569
BT 359 CTRP2 8.6654 10.1941 6.5081 0.4191
BT 328 CTRP2 8.75 9.9534 6.6312 0.153
BT 228 CTRP2 8.9508 10.1843 6.6243 0.1191
BT 231 CTRP2 9.3667 19.227 2.7464 13.3467
BT 286 CTRP2 10.4235 26.0599 0.1678 19.483
BT 504 CTRP2 10.494 26.2171 0.142 19.4443
BT 145 CTRP2 11.0989 23.244 1.2036 12.0844
BT 440 CTRP2 11.3895 36.5794 -4.2932 26.883
BT 187 CTRP2 11.7768 20.8638 3.5477 7.3761
BT 216 CTRP2 11.92 27.3611 0.5884 16.2884
BT 112 CTRP2 12.0233 29.9307 -1.3585 18.0356
BT 444 CTRP2 12.4035 26.918 1.1224 14.2068
BT 159 CTRP2 13.658 40.6522 -4.6345 24.6458
BT 179 CTRP2 14.777 40.7801 -4.6954 21.4934
BT 224 CTRP2 15.7148 32.0758 -0.0693 10.676
BT 139 CTRP2 16.7668 40.8794 -2.6376 17.9441
⏷ Show the Full List of 91 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Tongue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
YD-38 CTRP2 7.3179 8.2433 6.6371 1.1342
Cancer Drug Sensitivity Data Curated from 69 Cell Line(s) in Central Nervous System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
D283 Med GDSC1; CTRP2 -3.003 7.1707 -4.1584 59.3119
AM-38 GDSC1; CTRP2 1.7452 5.0832 1.6538 35.5854
MOG-G-CCM GDSC1 3.7797 7.1905 1.7546 10.7161
KS-1 [Human Krukenberg tumour] GDSC1 4.1064 18.4626 -3.605 32.9357
H4 GDSC1 4.4952 7.0198 2.3352 4.4136
D-502MG GDSC1; GDSC2 4.6522 7.3531 2.2775 3.5984
PFSK-1 GDSC1 4.8728 9.6641 1.3317 10.5495
D-392MG GDSC1 4.8965 9.0435 1.6429 8.3598
MOG-G-UVW GDSC1 5.0528 14.8054 -1.0489 22.8148
D-566MG GDSC1; GDSC2 5.1125 11.6958 0.5171 12.5907
D-542MG GDSC1; GDSC2 5.1321 6.7937 2.764 0.6631
M059J GDSC1 5.2135 6.873 2.7682 0.7415
D-263MG GDSC1 5.2355 12.0799 0.4169 15.2561
D-336MG GDSC1; GDSC2 5.3257 11.1209 0.9394 9.8758
CAS-1 GDSC1 5.3654 7.1211 2.7377 0.7456
LNZTA3WT4 GDSC1 5.4479 7.0887 2.7829 0.5266
LN-405 GDSC1 5.6691 6.9749 2.9043 0.1418
SNU-466 CTRP2 5.722 10.8079 3.9605 15.6389
GI-1 GDSC1 5.7459 7.7325 2.6647 0.7488
D-247MG GDSC1; GDSC2 5.7637 13.251 0.2154 12.7151
SF268 GDSC1; CTRP2 5.7713 7.0547 5.648 8.8009
D-423MG GDSC1; GDSC2 5.9033 10.4715 1.6003 5.2454
D-245MG GDSC2 5.9419 9.1594 2.1894 2.2681
Onda 10 GDSC1; GDSC2 5.9464 8.9215 2.2893 1.8261
KINGS-1 GDSC1 5.9471 7.9968 2.6478 0.6787
KNS-81-FD GDSC1; GDSC2 6.0042 14.583 -0.2605 14.4609
Onda 11 GDSC1; GDSC2 6.2421 8.4371 2.603 0.5251
SK-MG-1 GDSC1 6.3046 7.8376 2.8335 0.1205
U-251MG GDSC1; CTRP2 6.6003 13.0708 3.6396 14.9718
KNS-60 CTRP2 6.8694 7.3924 6.6983 1.6957
GB-1 GDSC1; CTRP2 6.9086 8.2505 6.3111 3.229
DBTRG-05MG GDSC1; CTRP2 7.0144 9.4125 5.0838 2.6899
U-87MG ATCC GDSC1; CTRP2 7.1121 9.0291 5.3199 1.6097
8-MG-BA GDSC1; CTRP2 7.1722 8.3408 6.4835 1.9997
CCF-STTG1 CTRP2 7.4006 8.6124 5.639 0.3238
SF539 GDSC1; CTRP2 7.4591 19.5467 1.1203 21.8933
LN-229 GDSC1; CTRP2; CTRP1 7.4773 8.8222 6.4968 1.6686
Daoy GDSC1; CTRP2 7.6194 11.9032 5.0599 7.189
DK-MG GDSC1; CTRP2 7.6468 8.7533 5.685 0.1466
KG-1-C CTRP2 7.8222 8.9008 5.6976 0.0927
SW1783 GDSC1; CTRP2 8.0433 12.2377 5.2088 5.8834
KNS-81 CTRP2 8.1555 9.495 6.554 0.5906
Hs 683 GDSC1; GDSC2; CTRP2 8.1692 9.726 6.4643 0.8566
NMC-G1 GDSC1; GDSC2; CTRP2 8.4267 9.7332 6.5828 0.3582
Becker GDSC1; CTRP2 8.4314 12.1084 5.5359 4.0092
SNU-489 CTRP2 8.4585 9.6335 6.6337 0.236
LN-18 GDSC1; CTRP2 8.6111 9.4474 6.7556 0.0389
U-118MG GDSC1; CTRP2 8.6964 13.8434 4.8859 6.2279
SF295 GDSC1; GDSC2; CTRP2; CTRP1 8.8134 10.0124 6.634 0.1345
SNU-738 CTRP2 8.8257 10.2719 6.5452 0.2755
SNU-626 CTRP2 8.8871 10.0281 6.6553 0.0944
GaMG GDSC1; CTRP2; CTRP1 9.0148 10.6609 6.4773 0.3389
42-MG-BA GDSC1; CTRP2 9.0192 11.29 6.2338 0.9349
KALS-1 GDSC1; CTRP2 9.0978 18.9364 2.694 13.9536
YKG-1 GDSC1; GDSC2; CTRP2 9.2927 10.5632 6.6159 0.0755
TM-31 CTRP2 9.3504 10.5149 6.6517 0.0436
A-172 GDSC1; CTRP2 9.3666 10.8328 6.55 0.1311
SNB-75 GDSC1; GDSC2; CTRP2 9.4479 12.0088 6.1439 0.9167
SNU-201 CTRP2 10.0303 27.9851 -1.07 22.9887
SW1088 GDSC1; CTRP2 10.7012 21.8396 2.41 12.5338
ONS-76 GDSC1; CTRP2 10.9837 18.8813 3.9786 6.7704
KNS-42 GDSC1; GDSC2; CTRP2 12.092 28.2521 0.2776 16.8761
SF126 GDSC1; GDSC2; CTRP2 12.1131 20.4064 3.9456 5.7007
SNU-1105 CTRP2 12.6278 27.4764 0.1917 13.2327
GMS-10 CTRP2 12.7141 29.6843 0.0119 16.7517
T98G GDSC1; CTRP2 12.9619 25.1687 2.2914 10.1112
YH-13 GDSC1; CTRP2 13.5865 32.8833 -0.9316 17.9099
M059K CTRP2 14.2519 29.4928 1.0879 12.1558
GOS-3 CTRP2 15.0316 30.0205 1.3136 10.7394
⏷ Show the Full List of 69 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Digestive System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
TGBC24TKB GDSC1 4.7342 12.1402 0.0273 18.7899
TGBC1TKB GDSC1 4.851 6.5564 2.7317 1.2663
ETK-1 GDSC1 5.575 10.4654 1.4076 8.3475
Cancer Drug Sensitivity Data Curated from 23 Cell Line(s) in Endometrium Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HEC-265 CTRP1 5.0242 7.035 4.0418 9.3049
RL95-2 GDSC1; CTRP2 5.2397 20.9731 -2.1007 30.9185
MFE-280 GDSC1 5.4145 7.687 2.5388 1.6048
HEC-151 CTRP2; CTRP1 5.605 7.2009 5.4313 10.3136
MFE-319 GDSC1; CTRP2; CTRP1 5.695 8.292 5.1027 11.1033
JHUEM-2 CTRP2; CTRP1 6.0852 7.1466 5.971 6.8992
AN3-CA GDSC1; CTRP2 6.5539 8.3611 5.9314 5.5997
KLE GDSC1; CTRP2; CTRP1 6.6035 8.3327 5.9921 5.2331
HEC-1-B CTRP2 6.6527 8.7708 5.1488 2.9429
ESS-1 GDSC1; CTRP2 6.8734 8.0869 6.3614 3.0919
HEC-50B CTRP2 6.8806 9.281 5.7729 5.5535
JHUEM-1 CTRP2 7.0552 8.3 6.4107 2.518
JHUEM-7 CTRP2 7.8786 9.1099 5.6454 0.1491
EN GDSC1; CTRP2 7.9093 9.9885 6.1972 2.0917
EFE-184 CTRP2 8.1786 10.2481 6.2408 1.6186
HEC-1-A CTRP2 8.4895 12.5954 5.3433 4.6937
JHUEM-3 CTRP2 9.2087 11.5983 5.2613 0.413
HEC-6 CTRP2; CTRP1 9.436 14.9366 4.8503 5.392
HEC-59 CTRP2; CTRP1 9.4835 15.1366 4.787 5.5744
MFE-296 GDSC1; CTRP2 9.9812 11.553 6.5208 0.0759
HEC-251 CTRP2; CTRP1 10.5604 17.7225 4.2543 6.2688
HEC-108 CTRP2; CTRP1 13.0403 20.9683 4.1961 4.0982
Ishikawa (Heraklio) 02 ER- CTRP2; CTRP1 8.286 9.0864 6.7642 0.0747
⏷ Show the Full List of 23 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 39 Cell Line(s) in Kidney Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SW13 GDSC1 3.4574 5.6773 2.2551 7.9315
SN12C GDSC1 4.2986 9.346 1.08 13.8722
A-704 GDSC1 4.6772 7.6002 2.179 5.1113
LB1047-RCC GDSC1; GDSC2 5.0094 12.1013 0.2467 14.214
NCC021 GDSC1; GDSC2 5.0554 7.8593 2.2831 2.9287
KTCTL-195 GDSC1 5.1204 7.0676 2.6513 1.3675
KTCTL-13 GDSC1; GDSC2 5.3244 7.167 2.703 0.7393
LB2241-RCC GDSC1; GDSC2 5.3327 7.8606 2.4284 1.8532
KTCTL-26A GDSC1; GDSC2 5.5193 9.1851 1.9558 3.9626
NCC010 GDSC1; GDSC2 5.6179 7.7521 2.604 0.8762
HA7-RCC GDSC1; GDSC2 5.6862 7.8378 2.6003 0.8417
KTCTL-140 GDSC1; GDSC2 5.829 7.9218 2.6281 0.6639
SW156 GDSC1; GDSC2 5.9862 8.3073 2.5481 0.8186
KTCTL-1M GDSC1; GDSC2 5.9935 8.2864 2.559 0.7797
TK-10 GDSC1 6.0387 8.5748 2.4683 1.308
RXF 393L GDSC1; GDSC2 6.0411 8.8897 2.3461 1.5059
BB65-RCC GDSC1; GDSC2 6.1399 12.6516 0.7442 9.3213
KTCTL-21 GDSC1; GDSC2 6.3944 8.8495 2.5123 0.6949
UO-31 GDSC1; GDSC2; CTRP2 6.7007 11.8922 4.3145 12.0326
TUHR14TKB CTRP2 7.5107 12.811 4.5243 9.6054
VMRC-RCZ GDSC1; CTRP2 7.6312 9.3202 6.3326 1.9206
TUHR10TKB CTRP2 7.7155 15.0207 3.5851 13.0152
RCC10RGB GDSC1; CTRP2; CTRP1 8.1302 9.5297 6.5607 0.725
SNU-1272 CTRP2 8.3266 10.15 6.3651 1.0474
KMRC-2 CTRP2 8.4356 9.8784 6.5301 0.4828
OS-RC-2 GDSC1; CTRP2 8.5247 10.1285 5.5264 0.1718
786-O GDSC1; CTRP2 8.6438 10.2857 5.515 0.1625
ACHN GDSC1; CTRP2 8.6836 10.756 6.2909 1.0001
BFTC-909 GDSC1; CTRP2 8.8619 10.2593 6.5641 0.2295
A-498 GDSC1; CTRP2 8.9155 10.0036 6.6737 0.0716
Caki-2 CTRP2 9.0349 10.5838 6.5137 0.2639
KMRC-20 GDSC1; CTRP2 9.0584 10.7062 6.4781 0.3215
TUHR4TKB CTRP2 9.074 10.1916 6.6653 0.0597
CAL-54 GDSC1; CTRP2 9.27 11.4432 6.2871 0.6488
KMRC-3 CTRP2 9.2886 11.6488 6.2146 0.8223
KMRC-1 GDSC1; CTRP2 9.432 10.9276 6.5408 0.1302
VMRC-RCW GDSC1; GDSC2; CTRP2; CTRP1 9.4478 15.9 4.4056 7.0787
769-P GDSC1; CTRP2 9.5153 11.1564 6.4915 0.1744
Caki-1 GDSC1; GDSC2; CTRP2 13.7088 25.7245 2.4808 8.7458
⏷ Show the Full List of 39 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 62 Cell Line(s) in Large Intestine Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SW1463 GDSC1 2.4569 4.4765 1.9267 14.5934
GP5d GDSC1 3.1588 5.424 2.132 9.9859
SW1116 GDSC1 3.4936 21.3403 -5.5446 37.6677
CaR-1 GDSC1 4.4762 6.0974 2.7371 1.752
COLO 320HSR GDSC1 5.2094 9.7392 1.5168 8.4642
HCC2998 GDSC1 5.3798 7.1048 2.7497 0.6887
CW-2 GDSC1; CTRP2; CTRP1 5.3925 7.4204 5.1301 12.0546
SNU-C5 GDSC1; CTRP2; CTRP1 5.4018 7.0697 5.2475 11.5958
HCT 116 GDSC1; CTRP2; CTRP1 5.4673 6.7033 5.4045 10.8334
SW837 GDSC1 5.5646 7.6794 2.6091 1.1167
SNU-283 GDSC2 5.5796 7.0988 2.8296 0.26
DiFi GDSC1 5.6049 7.8713 2.5521 1.3373
SNU-81 GDSC1; GDSC2; CTRP1 5.6859 7.0034 5.5753 10.4422
CCK-81 GDSC1 5.7452 7.8682 2.6136 0.9452
SNU-C4 CTRP2; CTRP1 5.8597 6.9291 5.7832 8.2652
RKO GDSC1; CTRP1 5.9344 7.0607 5.8312 10.0422
SNU-175 CTRP1 5.9609 7.7643 5.6146 18.4086
KM12 GDSC1; CTRP1 5.9944 7.3249 5.815 9.8903
SW626 GDSC1 6.0198 7.9773 2.6831 0.5263
SW948 GDSC1; CTRP2; CTRP1 6.1596 8.6231 5.4418 8.7708
NCI-H508 GDSC1; GDSC2; CTRP1 6.2493 7.9163 5.8521 7.5452
COLO 320 CTRP2; CTRP1 6.3122 9.6673 5.0899 9.8526
SNU-C2B GDSC1 6.5014 9.6034 2.271 1.7584
LS180 GDSC1; CTRP2; CTRP1 6.551 8.3623 5.9472 5.7633
LS123 GDSC1; CTRP2; CTRP1 6.5616 7.42 6.3878 3.9613
COLO 678 GDSC1; CTRP2; CTRP1 6.6027 9.047 5.663 6.8209
HT115 GDSC1; GDSC2; CTRP2; CTRP1 6.6362 7.5261 6.4203 3.635
CL-34 CTRP1 6.6424 7.6037 6.3921 7.9892
LoVo GDSC1; CTRP2; CTRP1 6.6488 9.3454 5.5581 7.157
SW480 CTRP1 6.67 8.2105 6.1338 10.0999
SNU-61 GDSC1; CTRP2; CTRP1 6.7489 10.4436 5.1017 8.8556
HT-55 GDSC1; CTRP2; CTRP1 6.8065 7.6007 6.5569 2.6572
T84 GDSC1; CTRP2 6.8385 12.8999 3.2539 10.9524
CL-40 CTRP1 6.8659 8.3218 6.2602 8.0386
SNU-407 GDSC1; CTRP2 7.0411 10.2688 5.4148 6.7467
CL-11 GDSC1; CTRP2 7.0493 10.1505 5.4807 6.4532
SW620 GDSC1; GDSC2; CTRP2; CTRP1 7.0864 8.2822 6.47 2.4262
RCM-1 [Human ESC] GDSC1; CTRP2; CTRP1 7.0923 7.8614 6.6851 1.5098
HCT 8 CTRP2; CTRP1 7.1419 8.0555 6.6279 1.6597
MDST8 GDSC1; CTRP2; CTRP1 7.3081 12.4827 4.5518 10.0568
COLO205 GDSC1; CTRP2; CTRP1 7.6178 9.0735 5.5551 0.4216
SW403 CTRP1 7.6228 9.5194 4.4387 0.6166
HCT 15 GDSC1; CTRP2 7.6668 9.3388 5.4731 0.6104
LS1034 GDSC1; CTRP2 7.7227 9.5693 5.4067 0.7655
C2BBe1 GDSC1; CTRP2; CTRP1 8.09 13.1918 4.7759 7.5848
SNU-C1 GDSC1; CTRP2 8.1133 10.2483 6.2024 1.8308
OUMS-23 CTRP2 8.134 10.3122 6.1856 1.8699
SW1417 GDSC1; CTRP2 8.1362 10.5748 6.0663 2.3179
HCC-56 CTRP2 8.3054 9.0945 6.7684 0.0665
SNU-1040 CTRP1 8.3198 10.0108 6.4541 1.9518
DLD-1 CTRP2; CTRP1 8.4145 9.2167 6.7653 0.0534
GP2d CTRP2; CTRP1 8.6374 21.1751 0.5161 17.8908
SK-CO-1 GDSC1; CTRP2; CTRP1 8.853 10.4878 6.4755 0.4078
LS411N GDSC1; CTRP2; CTRP1 8.8689 10.1116 6.6196 0.1418
HT-29 GDSC1; GDSC2; CTRP2; CTRP1 8.9138 10.0595 6.69 0.0978
NCI-H747 GDSC1; CTRP2 8.9819 29.3331 -2.545 27.4789
LS513 GDSC1; CTRP2; CTRP1 9.1488 10.3962 6.6222 0.0886
SW48 GDSC1; CTRP2; CTRP1 9.1567 10.742 6.5037 0.2443
NCI-H716 GDSC1; CTRP2 9.4384 29.1943 -2.8381 24.8868
SNU-503 CTRP2 9.4708 36.9518 -5.954 31.6098
SNU-1033 CTRP2 9.7093 11.8087 6.3318 0.3728
SNU-C2A CTRP2; CTRP1 11.1012 20.8602 3.1354 9.571
⏷ Show the Full List of 62 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Leukemia Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MO-T GDSC1 6.5418 25.1645 -5.0458 30.212
Cancer Drug Sensitivity Data Curated from 26 Cell Line(s) in Liver Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
Huh-7 GDSC1 5.0523 6.6859 2.7712 0.865
JHH-7 GDSC1 5.3115 6.9429 2.7822 0.6156
Hep-G2/C3A GDSC1 5.3132 6.668 2.8825 0.2991
HLE GDSC1 6.0832 8.0276 2.6892 0.4778
SNU-761 CTRP2 6.6574 20.9701 -0.2579 27.0244
SNU-182 CTRP2 6.7124 16.7684 1.8887 21.0464
SNU-398 GDSC1; CTRP2; CTRP1 6.7428 8.194 6.2103 4.2337
HuH-6 CTRP2 6.9649 14.482 3.2446 15.7599
JHH-4 GDSC1; CTRP2 7.2241 8.9149 6.2385 2.9366
JHH-1 GDSC1; CTRP2 7.2788 8.4201 6.5239 1.6554
SNU-886 CTRP2 7.5071 9.4807 5.3377 1.1518
HLF CTRP2 7.5292 13.2433 4.3236 10.3975
PLC/PRF/5 CTRP2 8.0852 11.4213 5.6332 4.094
SK-HEP-1 GDSC1; CTRP2 8.2596 10.1974 6.3088 1.2967
JHH-6 GDSC1; CTRP2; CTRP1 8.2883 9.1852 6.7304 0.1201
Hep 3B2.1-7 GDSC1; GDSC2; CTRP2 8.2982 9.6599 5.6067 0.1153
HuH-1 GDSC1; CTRP2 8.4468 9.6607 6.6189 0.2703
SNU-423 GDSC1; CTRP2 8.5561 13.6707 4.8733 6.479
SNU-878 CTRP2 8.7293 15.5442 4.0866 9.3493
Hep-G2 CTRP2; CTRP1 8.8578 10.0636 6.6682 0.1355
SNU-449 GDSC1; CTRP2; CTRP1 8.905 12.7076 4.6865 2.1691
JHH-2 GDSC1; CTRP2 9.0138 10.837 6.4104 0.4819
JHH-5 CTRP2 9.2819 18.1783 3.197 11.8711
Li-7 CTRP2 9.415 11.2857 6.407 0.3327
SNU-387 GDSC1; CTRP2 9.9686 18.1897 3.6619 9.1755
SNU-475 CTRP2 12.1668 27.3056 0.7813 15.4483
⏷ Show the Full List of 26 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 226 Cell Line(s) in Lung Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
LC-1F CTRP2 0.3443 32.3054 -16.5073 41.894
NCI-H82 GDSC1; CTRP1 1.0823 7.9609 -0.3129 44.0575
NCI-H2795 GDSC1 1.7404 11.4885 -2.1442 37.48
DMS 454 CTRP2 1.7952 4.2016 -1.7466 1.234
NCI-H1648 GDSC1 2.0117 5.1522 1.1719 22.2217
NCI-H211 GDSC1; CTRP2 3.4495 14.0178 0.2336 33.5275
NCI-H2227 GDSC1; GDSC2 3.8087 10.8208 -0.03 18.6604
Ms-1 GDSC1 3.9671 7.0684 1.9554 8.6156
CPC-N GDSC1 4.162 6.5147 2.3597 5.0278
NCI-H1963 GDSC1; CTRP1 4.2656 5.4178 4.2606 23.8202
NCI-H1304 GDSC1 4.3819 7.9046 1.8424 8.272
NCI-H2373 GDSC1 4.4766 7.1537 2.2616 4.9808
DMS 79 GDSC1; GDSC2 4.4808 7.5674 2.0699 5.1183
NCI-H345 GDSC1; GDSC2 4.5738 5.2273 3.1136 0.044
COR-L321 GDSC1; GDSC2 4.6393 7.584 2.1631 4.272
NCI-H2369 GDSC1 4.6796 6.1809 2.803 1.0974
NCI-H1688 GDSC1 4.7135 7.1079 2.4243 3.3483
IST-SL2 GDSC1; GDSC2 4.7213 9.5814 1.2677 9.327
PaCa-3 GDSC1 4.7268 7.105 2.4332 3.2642
NCI-H510A GDSC1; GDSC2 4.764 8.7918 1.6753 6.8663
NCI-H1048 GDSC1; CTRP1 4.7953 6.3143 4.2 6.4027
NCI-H847 GDSC1 4.8166 8.1867 1.9936 6.0996
NCI-H2171 GDSC2 4.8289 6.9077 2.5745 1.7576
NCI-H290 GDSC1; GDSC2 4.8841 8.1891 2.0342 4.567
Lu-165 GDSC1 4.9161 7.5499 2.3422 3.5111
LCLC-97TM1 GDSC1; CTRP1 4.9168 10.5952 2.1715 18.4966
NCI-H446 GDSC1; CTRP2 4.9335 9.4444 3.8165 18.1809
COR-L51 CTRP2; CTRP1 4.9537 25.4025 -3.9214 36.5772
NCI-H2731 GDSC1 4.9684 7.4523 2.4137 2.9579
NCI-H2803 GDSC1; GDSC2 5.0071 6.8077 2.7031 0.9899
NCI-H64 GDSC1 5.1126 6.322 2.9299 0.2609
NCI-H2591 GDSC1 5.1277 10.1357 1.2769 10.2585
NCI-H1876 GDSC1; CTRP1 5.1437 7.6081 4.7966 17.9086
NCI-H209 GDSC1 5.1681 14.8783 -0.9991 22.2956
NCI-H187 GDSC1 5.171 6.2636 2.9713 0.1491
NCI-H250 GDSC2 5.2184 7.0081 2.7186 0.7602
NCI-H1694 GDSC1; CTRP2; CTRP1 5.2205 6.7466 5.1284 12.5822
NCI-H524 GDSC1 5.2381 11.0441 0.9174 12.2778
NCI-H2810 GDSC1; GDSC2 5.2483 8.0313 2.3127 2.511
NCI-H1930 CTRP1 5.261 7.1622 4.1706 7.2047
A-427 GDSC1; GDSC2 5.2755 7.8683 2.3964 2.0693
NCI-H740 GDSC2 5.3472 8.4368 2.1899 2.9968
Lu-139 GDSC1 5.3744 21.6898 -4.2126 31.0692
NCI-H748 GDSC2 5.4175 7.8272 2.4835 1.5184
NCI-H1836 GDSC1; GDSC2; CTRP1 5.418 6.815 5.3284 12.3139
Lu-99A GDSC1 5.423 7.744 2.5198 1.6924
UMC-11 GDSC1 5.4457 7.3138 2.6983 0.8401
NCI-H1436 GDSC1; GDSC2 5.4628 6.9423 2.8413 0.2754
NCI-H146 GDSC1; GDSC2 5.4804 9.0968 1.9731 3.9298
NCI-H2818 GDSC1 5.4952 7.4439 2.6697 0.9173
Lu-135 GDSC1 5.5509 12.0857 0.6295 13.2151
NCI-H1770 GDSC1; GDSC2 5.5553 11.2723 1.0183 8.9875
NCI-H23 GDSC1; CTRP2; CTRP1 5.5642 11.8974 3.2838 18.6701
NCI-H322M GDSC1 5.582 12.1024 0.6423 13.0628
NCI-H2135 GDSC1; GDSC2 5.5894 8.1143 2.4482 1.5007
NCI-H810 GDSC1; CTRP2; CTRP1 5.6025 6.6674 5.5533 9.6645
NCI-H1651 GDSC1 5.643 8.3383 2.3825 2.1497
NCI-H2141 GDSC1; CTRP2; CTRP1 5.6683 8.2788 5.0948 11.4186
COR-L303 GDSC2 5.7007 7.1577 2.8532 0.1817
NCI-H2106 CTRP2 5.7121 6.7169 5.6628 8.9321
NCI-H1993 GDSC1 5.7127 7.4227 2.7647 0.4405
NCI-H2066 GDSC1 5.7267 7.4481 2.7609 0.4446
NCI-H1105 GDSC1; GDSC2; CTRP2; CTRP1 5.7523 7.699 5.4184 9.9351
LK-2 GDSC1 5.772 7.3813 2.8014 0.3172
NCI-H2722 GDSC1 5.774 7.4301 2.7851 0.3573
EMC-BAC-1 GDSC1; GDSC2 5.7972 10.6861 1.4411 6.2632
HOP-62 GDSC1; CTRP2 5.8069 6.6688 5.773 8.2445
NCI-H2342 GDSC1; CTRP2; CTRP1 5.8115 7.4962 5.5573 9.2397
NCI-H1581 GDSC1; CTRP2 5.8199 6.7325 5.7763 8.1915
LC-1/sq GDSC1 5.8426 13.9291 -0.0564 16.2144
COR-L279 GDSC1; CTRP1 5.8515 8.2219 4.0792 4.3402
ABC-1 GDSC1; GDSC2 5.8544 7.945 2.6298 0.6445
NCI-H1155 GDSC1; CTRP2 5.8717 7.2425 5.7003 8.3077
NCI-H513 GDSC1 5.8984 7.9319 2.6523 0.6936
SCLC-21H CTRP1 5.9032 7.2975 5.7253 17.8681
IST-SL1 GDSC1; GDSC2 5.9072 7.9302 2.6564 0.5413
COR-L23 GDSC1; CTRP1 5.9164 7.2288 5.7618 10.4351
COR-L32 GDSC2 5.9357 7.7132 2.7454 0.3146
NCI-H2461 GDSC1 5.9617 7.6884 2.7637 0.3357
SBC-1 GDSC1; GDSC2 5.9678 14.6119 -0.2992 14.7115
NCI-H526 GDSC1; CTRP2 5.973 10.0716 4.5542 12.6362
SBC-3 GDSC1 6.0129 7.9181 2.7016 0.476
EMC-BAC-2 GDSC1 6.0266 8.0099 2.674 0.5501
NCI-H1341 GDSC1; CTRP2 6.0436 13.0351 2.5484 15.5052
NCI-H69 GDSC1; CTRP2 6.0502 8.9931 5.1435 10.0369
DV-90 CTRP2; CTRP1 6.0597 6.8663 6.0099 6.6102
NCI-H1781 GDSC1; CTRP1 6.1115 7.6786 5.8083 9.4997
NCI-H2595 GDSC1 6.1135 15.5424 -0.6473 18.3505
LB647-SCLC GDSC1; GDSC2 6.1608 15.9702 -0.8211 16.5614
NCI-H1573 GDSC1; CTRP1 6.1674 12.2396 2.3453 13.9924
NCI-H2869 GDSC1; GDSC2 6.1883 8.1131 2.6983 0.3272
NCI-H2347 GDSC1 6.2777 8.0823 2.7415 0.277
NCI-H3122 GDSC1 6.2786 8.1023 2.7349 0.2902
Lu-134-A GDSC1; GDSC2 6.3015 8.4194 2.6321 0.43
NCI-H835 GDSC1 6.3084 8.373 2.6513 0.4792
NCI-H2087 GDSC1; CTRP2 6.3571 8.813 5.5263 7.7322
NCI-H1184 CTRP2 6.36 9.7463 5.0755 9.5942
NCI-H596 GDSC1; CTRP1 6.3661 7.3066 6.2232 6.5618
RERF-LC-Sq1 GDSC1 6.3793 23.7574 -4.4732 29.4247
NCI-H1092 GDSC1; CTRP2 6.4243 12.2836 3.2354 11.8286
NCI-H3255 GDSC1; GDSC2; CTRP1 6.4275 7.517 6.2071 5.5007
LC-2/ad GDSC1; GDSC2 6.4468 8.2865 2.7316 0.1988
NCI-H1385 CTRP2 6.4685 7.6402 6.1831 4.7848
RERF-LC-KJ GDSC1; CTRP1 6.4989 8.3488 4.4024 1.4369
HCC4006 CTRP2; CTRP1 6.5622 7.9571 6.1498 4.9086
HCC44 GDSC1; CTRP2; CTRP1 6.622 9.6737 5.3499 7.8731
NCI-H1944 GDSC1; CTRP2; CTRP1 6.627 13.4975 3.4497 15.6613
NCI-H441 GDSC1; CTRP1 6.6358 8.0976 6.1553 6.0134
Sq-1 CTRP2; CTRP1 6.6478 8.4075 6.0174 5.2487
NCI-H2170 GDSC1; CTRP2 6.6577 8.5663 5.9288 5.3734
NCI-H2286 CTRP1 6.7341 11.2055 3.2445 10.1738
NCI-H2081 GDSC1; GDSC2; CTRP2; CTRP1 6.785 8.9776 5.8626 5.5909
SBC-5 GDSC1; CTRP2 6.8318 8.9348 5.903 5.1059
NCI-H1666 GDSC1; CTRP2; CTRP1 6.854 8.4863 6.1457 4.0387
HCC1359 CTRP1 6.8761 9.2827 5.7912 12.1749
NCI-H841 GDSC1; CTRP2; CTRP1 6.8932 8.1397 6.3749 3.2162
Calu-6 GDSC1; CTRP2; CTRP1 6.9132 8.5995 6.1411 3.9356
COR-L95 GDSC1; CTRP2 6.9475 8.9568 5.2543 2.072
CAL-12T GDSC1; GDSC2; CTRP2; CTRP1 6.9798 8.3914 6.3256 3.2429
NCI-H661 GDSC1; CTRP2; CTRP1 6.9852 12.9401 4.0325 12.6146
NCI-H520 GDSC1; CTRP2 7.069 9.8023 5.6711 5.6119
NCI-H522 CTRP2; CTRP1 7.144 14.0286 3.6201 13.9525
NCI-H1915 GDSC1; CTRP2; CTRP1 7.1539 8.4509 6.4145 2.321
NCI-H2444 GDSC1; GDSC2; CTRP2 7.1612 8.8465 6.2233 3.1123
NCI-H647 GDSC1; GDSC2; CTRP2 7.1809 9.0209 6.152 3.3768
ChaGo-K-1 GDSC1; GDSC2; CTRP2; CTRP1 7.182 11.1865 5.0717 7.9237
LUDLU-1 CTRP2 7.1957 20.5229 0.416 24.3226
NCI-H2122 GDSC1; CTRP2; CTRP1 7.2342 8.4561 6.5004 2.0327
RERF-LC-MS GDSC1; GDSC2; CTRP2 7.2747 9.909 5.7836 4.7581
NCI-H1435 GDSC1; CTRP2; CTRP1 7.3168 11.5062 5.0209 7.8876
RERF-LC-A1 CTRP2 7.3182 9.2378 6.1505 3.1439
SW1271 GDSC1; CTRP2 7.3627 8.8764 6.3614 2.1948
BEN GDSC1; GDSC2; CTRP2; CTRP1 7.3879 8.231 5.7727 0.0816
NCI-H2073 CTRP1 7.3915 8.7329 6.4802 3.9893
LC-1/sq-SF CTRP2; CTRP1 7.4123 10.0022 5.0558 2.299
NCI-H2029 GDSC1; GDSC2; CTRP2; CTRP1 7.5161 10.5693 4.8591 2.96
LCLC-103H GDSC1; CTRP2; CTRP1 7.5246 8.6995 5.6573 0.2329
NCI-H2196 GDSC2; CTRP2 7.542 9.4701 5.3599 1.0472
NCI-H2804 GDSC1; GDSC2 7.558 21.0299 -2.2989 19.2051
NCI-H1437 GDSC1; GDSC2; CTRP1 7.581 9.6123 4.3883 0.5001
NCI-H1734 GDSC1; GDSC2; CTRP2 7.5908 9.8945 6.028 3.2142
LK2 CTRP2 7.6806 8.3711 5.8257 0.0123
NCI-H2291 GDSC1; GDSC2; CTRP2 7.6899 9.9755 6.0583 2.9421
SK-LU-1 GDSC1; CTRP2; CTRP1 7.69 9.4615 6.334 2.025
NCI-H2405 GDSC1; CTRP2; CTRP1 7.6956 9.9496 5.2356 1.3382
NCI-H720 GDSC1 7.7042 25.8815 -4.5471 26.9853
DMS 273 GDSC1; CTRP2; CTRP1 7.7044 22.8092 -0.3101 25.142
NCI-H1568 GDSC1; CTRP2; CTRP1 7.7077 15.5234 2.6095 12.0701
HCC33 GDSC2; CTRP1 7.7145 14.7113 2.2258 9.5174
HCC827 GDSC1; CTRP2; CTRP1 7.7301 11.4189 5.4099 5.7455
EPLC-272H GDSC1; CTRP2; CTRP1 7.7733 12.8227 4.7218 8.3298
NCI-H838 GDSC1; GDSC2; CTRP2 7.7821 8.9526 5.665 0.1433
NCI-H226 GDSC1; CTRP2 7.7881 9.5596 6.321 1.7632
RERF-LC-Ad1 CTRP2 7.8016 9.0836 6.5459 0.9111
NCI-H727 GDSC1; CTRP2; CTRP1 7.8624 10.2754 5.183 1.3737
NCI-H1838 GDSC1; CTRP2 7.8624 11.0071 5.6792 4.2318
NCI-H1650 GDSC1; CTRP2 7.9426 14.5383 4.0011 10.9719
COLO 668 GDSC1; CTRP2; CTRP1 8.0345 12.5759 5.0373 6.6011
COR-L105 GDSC1; CTRP2 8.0703 9.9469 6.3135 1.4686
PC-14 GDSC1; GDSC2; CTRP2 8.0947 10.8379 5.9171 2.9492
RERF-LC-Ad2 CTRP2 8.1206 9.5821 5.5688 0.2054
NCI-H1339 CTRP2 8.1326 9.9222 6.3598 1.2409
VMRC-LCD GDSC1; CTRP2; CTRP1 8.1455 10.0564 5.4036 0.5322
IA-LM GDSC1; CTRP2 8.1796 9.6029 5.5835 0.1685
SK-MES-1 GDSC1; CTRP2 8.2075 10.5071 6.1406 1.9551
NCI-H2110 GDSC1; GDSC2; CTRP2; CTRP1 8.2199 13.0496 4.9674 6.7877
NCI-H1355 GDSC1; CTRP2; CTRP1 8.2239 13.0925 4.921 6.7819
NCI-H2085 GDSC1; CTRP2 8.2364 14.317 3.5613 7.3404
NCI-H2126 CTRP2; CTRP1 8.3557 9.6103 6.5996 0.3529
NCI-H1755 GDSC1; CTRP2; CTRP1 8.3645 12.0659 5.542 4.2577
NCI-H322 CTRP2 8.515 10.5299 6.3009 1.0996
COR-L88 GDSC1; CTRP2; CTRP1 8.5368 18.7466 2.3696 16.0015
HCC95 CTRP2 8.5586 10.4003 6.3769 0.8319
HCC1833 CTRP2; CTRP1 8.6087 10.9581 6.199 1.504
NCI-H2009 GDSC1; CTRP2; CTRP1 8.6398 12.7253 5.3799 4.3502
HCC1195 CTRP2; CTRP1 8.6552 10.9611 6.2226 1.3834
MOR/CPR CTRP2 8.6591 9.43 6.7775 0.022
SHP-77 GDSC1; CTRP2; CTRP1 8.6868 10.8876 6.2373 1.1642
NCI-H358 GDSC1; CTRP2; CTRP1 8.7255 13.3427 5.1439 5.1648
HCC1438 CTRP2 8.7447 9.8729 6.6576 0.1179
NCI-H1975 GDSC1; CTRP2; CTRP1 8.8084 14.0341 4.87 6.1347
LOU-NH91 GDSC1; CTRP2 8.8543 15.667 4.1152 9.0473
NCI-H460 GDSC1; GDSC2; CTRP2; CTRP1 8.8805 9.7321 6.7884 0.0234
NCI-H889 CTRP2 8.8836 10.6223 6.4371 0.5539
DMS 53 GDSC1; CTRP2 8.8859 11.5852 6.043 1.6297
NCI-H1563 GDSC1; CTRP2 8.8886 10.565 6.4612 0.4239
HCC78 GDSC1; CTRP2; CTRP1 8.8928 15.7327 3.3184 7.4034
NCI-H1703 GDSC1; CTRP2 9.1138 13.9476 4.2626 3.478
HCC1588 CTRP2 9.1462 10.5368 6.5728 0.1451
NCI-H2172 GDSC1; GDSC2; CTRP1 9.1728 12.846 5.6793 3.0335
HCC2108 CTRP2; CTRP1 9.2496 13.1056 5.6071 2.9533
DMS 114 GDSC1; CTRP2 9.2956 10.7797 6.5426 0.1534
NCI-H2023 GDSC1; CTRP2; CTRP1 9.3569 15.1501 4.7306 6.1217
NCI-H1869 GDSC1; CTRP2 9.3677 12.8572 5.7498 2.1845
T3M-10 CTRP2; CTRP1 9.3703 17.6598 3.5392 10.6436
NCI-H1693 GDSC1; CTRP2 9.4778 10.9826 6.5382 0.1253
NCI-H1793 GDSC1; CTRP2; CTRP1 9.4944 11.6222 6.3141 0.4857
NCI-H196 GDSC1; CTRP2 9.5317 19.0399 2.9546 12.3618
NCI-H1395 CTRP2 9.5617 18.0946 3.433 10.5893
NCI-H1299 GDSC1; CTRP2; CTRP1 9.6179 11.4951 6.41 0.2675
NCI-H1373 CTRP2; CTRP1 9.6287 17.4792 3.7741 9.2282
EBC-1 GDSC1; CTRP2; CTRP1 9.6756 19.0206 3.0647 11.756
NCI-H2228 GDSC1; CTRP2 9.8542 25.5496 -0.0002 20.7704
HOP-92 GDSC1; CTRP2 9.9393 14.1071 5.5141 2.4678
HCC366 GDSC1; GDSC2; CTRP2 10.007 11.5665 6.5251 0.0703
Calu-3 GDSC1; CTRP2; CTRP1 10.0123 24.5306 0.6178 18.9221
NCI-H1792 GDSC1; CTRP2; CTRP1 10.019 18.2682 3.6579 9.1221
Lu-99 CTRP2; CTRP1 10.1086 18.511 3.6016 9.2076
HARA [Human squamous cell lung carcinoma] GDSC1; CTRP2; CTRP1 10.2506 17.1612 4.3241 6.3762
HCC2935 CTRP2; CTRP1 10.2522 19.3124 3.3454 10.0964
NCI-H1623 GDSC1; CTRP2 10.3127 22.0593 1.2537 12.9752
LXF 289 GDSC1; CTRP2; CTRP1 11.1597 29.7154 -1.0881 21.3879
A-549 GDSC1; CTRP2; CTRP1 11.2734 19.3905 3.9191 6.6558
NCI-H292 GDSC1; GDSC2; CTRP2 11.3785 29.3847 -0.7691 20.3727
NCI-H2030 GDSC1; GDSC2; CTRP2; CTRP1 11.402 18.3733 4.4798 4.7498
EKVX GDSC1; GDSC2; CTRP2 11.7252 23.7817 2.163 11.9749
KNS-62 GDSC1; CTRP2; CTRP1 11.7523 20.5816 3.6611 7.0198
HCC2279 CTRP2 11.9065 22.8546 2.7119 10.0013
Lu-65 GDSC1; CTRP2; CTRP1 12.2405 24.3538 2.2233 11.1529
SW1573 GDSC1; CTRP2 12.2772 25.8674 1.5368 13.1781
NCI-H650 GDSC1; CTRP2; CTRP1 12.6998 24.9525 1.392 9.5915
HCC1171 CTRP2 13.0157 31.2783 -0.5476 17.7245
COLO 699 CTRP2; CTRP1 13.307 28.4435 1.0171 13.5273
HCC15 GDSC1; CTRP2; CTRP1 14.4437 35.4259 -1.5428 18.3316
Calu-1 CTRP2 14.4728 33.3057 -0.55 16.0185
Hs 888.Lu CTRP2 11.444 21.8642 2.8831 9.998
⏷ Show the Full List of 226 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Lymphoma Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
CBTCi002-A GDSC1 5.9155 7.6921 2.7453 0.4007
Cancer Drug Sensitivity Data Curated from 47 Cell Line(s) in Ovary Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
2004 CTRP2 7.1225 18.3492 1.4422 21.6027
SNU-119 CTRP2 1.4134 21.3415 -5.2183 45.1404
Caov-4 GDSC1 4.0271 5.9237 2.5514 3.9468
OVCAR-3 GDSC1 4.8438 11.4487 0.4465 16.1747
OVCAR-8 GDSC1; CTRP2; CTRP1 5.1965 7.0399 5.0315 13.0022
ES-2 GDSC1 5.2156 6.4884 2.9095 0.2704
JHOS-4 GDSC1; GDSC2; CTRP1 6.0459 9.7288 3.4866 6.3159
A2780 GDSC1; CTRP2; CTRP1 6.1955 7.8993 5.8039 7.2292
OVCAR-4 GDSC1; CTRP2; CTRP1 6.2697 11.2182 4.2897 13.2493
RMUG-S CTRP1 6.2749 8.5214 5.6032 16.7381
OVKATE GDSC1; CTRP1 6.3825 7.8907 5.9997 7.6179
JHOM-1 CTRP2; CTRP1 6.4067 7.1588 6.3175 4.6676
JHOC-5 CTRP2; CTRP1 6.4181 7.9582 6.0055 5.8508
OVCAR-5 GDSC1; CTRP2 6.4226 7.4446 6.2186 4.7676
OV-90 GDSC1; CTRP2; CTRP1 6.5571 9.8924 5.2049 8.8303
TYK-nu GDSC1; CTRP2; CTRP1 6.5892 7.8123 6.2437 4.4621
COV318 CTRP1 6.6469 8.1712 4.5437 0.957
RMG-I GDSC1; CTRP2; CTRP1 6.6812 9.3441 5.5881 6.9616
HEY A8 CTRP2; CTRP1 6.6956 7.162 6.6198 2.4616
COV434 CTRP2; CTRP1 6.6996 9.9181 5.3198 8.045
IGROV-1 GDSC1; CTRP2; CTRP1 6.8126 8.6019 6.0736 4.649
OVK18 GDSC1; GDSC2; CTRP2; CTRP1 6.9181 7.964 6.4842 2.7053
EFO-27 GDSC1; GDSC2; CTRP2; CTRP1 7.0905 8.7048 6.2621 3.2931
TOV-21G GDSC1; CTRP2 7.1894 8.5824 6.3769 2.4167
COV644 CTRP2; CTRP1 7.2146 9.4154 6.0077 4.1326
Caov-3 GDSC2; CTRP2; CTRP1 7.4201 9.1151 6.314 2.5024
TOV-112D GDSC1; CTRP2 7.4282 9.2962 6.2034 2.7444
COV362 CTRP2; CTRP1 7.5568 9.289 6.3266 2.2426
OVMANA CTRP1 7.7917 9.1035 4.642 0.0872
JHOS-2 GDSC1; GDSC2; CTRP2 7.832 16.8257 2.0613 13.9831
EFO-21 GDSC1; CTRP2; CTRP1 7.8984 9.3616 5.5625 0.2857
OVSAHO CTRP2 7.9387 9.6004 5.4899 0.425
ES2 CTRP2 8.1715 10.0259 6.3356 1.2878
OV56 GDSC1; CTRP2 8.4727 9.3363 6.7451 0.0648
OVISE GDSC1; CTRP2 8.5215 9.7524 6.6151 0.2494
OAW42 GDSC1; CTRP2; CTRP1 8.5524 9.5115 6.7492 0.0936
SNU-8 CTRP2 8.7499 11.6655 5.9334 2.1352
OV7 CTRP2; CTRP1 8.8205 10.9702 6.3031 0.9979
FU-OV-1 GDSC1; CTRP2 9.1051 10.8692 6.4364 0.3869
OC 314 GDSC1; CTRP2 9.1399 10.3991 6.6181 0.0941
ONCO-DG-1 CTRP2 9.1848 10.7994 6.4939 0.2525
DOV13 GDSC1; CTRP2 9.3333 11.4391 6.316 0.5506
Kuramochi GDSC1; CTRP2 9.8832 11.8207 6.3941 0.2256
SK-OV-3 GDSC1; CTRP2; CTRP1 10.7896 18.1607 4.1915 6.2346
OAW28 GDSC1; CTRP2 12.3774 22.8642 2.9942 8.5478
SNU-840 CTRP2; CTRP1 13.507 25.2845 2.5937 8.741
OVTOKO GDSC1; CTRP2 14.2302 28.9855 1.3079 11.5801
⏷ Show the Full List of 47 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 3 Cell Line(s) in Thigh Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
H-STS CTRP2 7.2944 24.0534 -1.9407 26.5891
P-STS CTRP2 7.5797 9.0509 5.5473 0.4608
SYO-1 CTRP2 8.1396 9.9179 6.3655 1.2142
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Clivus Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
U-CH1 CTRP2 7.9705 29.583 -4.1608 29.484
Cancer Drug Sensitivity Data Curated from 31 Cell Line(s) in Soft Tissue Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
Aska-SS CTRP2 8.4349 9.7676 6.5731 0.377
Yamato-SS CTRP2 8.6586 9.9638 6.592 0.2451
Rh41 GDSC1; CTRP2 1.0709 12.0848 -1.3165 43.5785
Hs 633.T GDSC1 3.666 18.5397 -4.0022 34.8818
EW-8 GDSC1 3.8078 5.9137 2.4053 5.6462
SW684 GDSC1 4.5078 6.4534 2.5991 2.5756
VA-ES-BJ GDSC1 5.1376 6.8801 2.733 0.9568
MFH-ino GDSC1 5.4026 7.1902 2.7271 0.7591
STS-0421 GDSC1; GDSC2 5.524 8.9532 2.0606 3.4116
Rh30 GDSC1 5.5953 7.1219 2.8273 0.3233
SW872 GDSC1 5.6349 7.5885 2.6732 0.7952
TTC-709 CTRP2 5.7651 7.1368 5.6174 8.9315
TE 441.T GDSC2; CTRP2 6.4 7.1252 6.3126 4.4739
Rh18 GDSC1 6.4367 15.144 -0.2383 15.6883
GCT GDSC1; CTRP2 6.677 17.0294 1.7282 21.629
A-204 GDSC1; CTRP2 6.795 22.1837 -0.7486 27.8348
HT-1080 GDSC1; CTRP2; CTRP1 7.1924 8.0353 6.677 1.3671
G-402 GDSC1; CTRP2 7.3469 13.9627 3.8188 12.7762
RKN GDSC1; CTRP2; CTRP1 7.4597 8.8202 6.4857 1.7389
BT-12 CTRP2 7.558 9.0343 6.4201 1.6714
SW982 GDSC1; CTRP2 7.6307 10.0022 6.004 3.252
MES-SA GDSC1; CTRP2 7.8438 9.079 6.571 0.7843
Tm87-16 CTRP2 8.287 10.8135 6.0483 2.2101
SK-LMS-1 GDSC1; CTRP2 8.3549 13.7033 4.7167 7.4104
G-401 GDSC1; CTRP2; CTRP1 8.4789 17.1865 3.0972 13.5274
BT-16 CTRP2 9.0494 10.4176 6.5789 0.1576
KYM-1 GDSC1; CTRP2 9.2601 10.6676 6.5687 0.1283
SK-UT-1 GDSC1; CTRP2 9.4137 15.0283 4.7935 5.6363
TE 617.T CTRP2 10.0753 20.1292 2.8057 12.0823
RD GDSC1; CTRP2 12.9185 25.0718 2.3096 10.1037
Hs 729.T CTRP2 13.4516 23.9759 3.1142 7.0685
⏷ Show the Full List of 31 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 8 Cell Line(s) in Pleura Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
MSTO-211H GDSC1; CTRP1 4.8965 9.9663 2.4685 16.9034
JL-1 CTRP2 8.3898 10.0167 5.5157 0.2186
NCI-H2052 GDSC1; CTRP2; CTRP1 8.7094 13.6103 5.0061 5.7322
ACC-MESO-1 CTRP2 9.137 10.3888 6.6206 0.092
NCI-H28 GDSC1; CTRP2; CTRP1 9.4521 11.7334 6.2539 0.6385
IST-Mes1 GDSC1; CTRP2 9.6025 11.2903 6.4767 0.1756
NCI-H2452 GDSC1; CTRP2 10.7732 22.5243 2.1306 13.3381
MPP 89 GDSC1; CTRP2 11.5788 27.1915 0.4362 17.1472
⏷ Show the Full List of 8 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 7 Cell Line(s) in Prostate Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
PC-3 GDSC1 4.8051 7.5657 2.2716 4.1978
NCI-H660 GDSC2; CTRP2 5.3902 9.5216 4.2441 15.3127
VCaP GDSC1; CTRP2 7.0493 12.1002 4.5059 10.5438
LNCaP clone FGC GDSC1; CTRP2 7.2913 9.8469 5.0544 2.4502
DU145 GDSC1; CTRP2 7.9912 10.6132 5.956 2.9321
PaCa-3 CTRP2; CTRP1 8.1155 9.2679 6.6272 0.4112
22Rv1 GDSC1; CTRP2 9.2666 15.9057 4.2831 7.7969
⏷ Show the Full List of 7 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 2 Cell Line(s) in Salivary Gland Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
A-253 GDSC1; CTRP2 6.6836 8.223 6.1207 4.516
YD-15 CTRP2 7.6215 20.2633 0.8943 22.2246
Cancer Drug Sensitivity Data Curated from 1 Cell Line(s) in Small Intestine Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
HuTu 80 GDSC1; GDSC2 5.3321 7.2438 2.6767 0.8261
Cancer Drug Sensitivity Data Curated from 44 Cell Line(s) in Stomach Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
NCC-StC-K140 CTRP2 1.9227 24.0724 -6.0528 44.385
RERF-GC-1B GDSC1 3.3046 8.6878 0.6246 20.1802
ECC10 GDSC1; CTRP2 3.5108 10.4333 1.9215 28.9119
HGC-27 GDSC1; CTRP2 4.5917 17.7935 -0.5023 32.0848
TGBC11TKB GDSC1 4.7409 7.1904 2.4031 3.4373
SCH GDSC1; GDSC2 4.9417 6.4392 2.8186 0.6073
SNU-16 GDSC1; CTRP2 5.1587 15.1483 1.318 26.2798
HSC-39 GDSC1 5.2598 7.5937 2.5033 1.9846
OCUM-1 GDSC1 5.6434 7.2622 2.7957 0.386
MKN28 GDSC1 5.7356 8.2841 2.4477 1.7034
GCIY GDSC1 5.8955 8.2487 2.5322 1.1583
SNU-5 GDSC1; CTRP2 5.9372 13.418 2.8806 19.3148
RF-48 GDSC1 6.1388 20.2535 -2.9264 26.2932
SK-GT-2 GDSC1 6.1764 8.1389 2.6847 0.4478
AGS GDSC1; CTRP2; CTRP1 6.2838 8.0433 5.8312 6.891
TMK-1 GDSC1; GDSC2 6.4503 8.0812 2.802 0.1093
GSS CTRP2 6.5897 18.0765 1.1307 23.6015
MKN74 CTRP2; CTRP1 6.9415 8.7787 6.0759 4.1531
NCI-N87 GDSC1; CTRP2 7.0083 8.9903 6.0266 4.229
MKN45 GDSC1; CTRP2 7.2324 8.2033 5.7233 0.208
Hs 746.T GDSC1; CTRP2 7.2811 8.5051 6.484 1.8168
GSU CTRP2 7.4258 8.4429 6.6136 1.0818
23132/87 GDSC1; CTRP2 7.4546 12.2199 4.7744 8.6683
SNU-620 CTRP2 7.7691 8.9474 6.5879 0.7959
SH-10-TC CTRP2; CTRP1 7.7745 8.8775 5.6885 0.1126
ECC12 GDSC2; CTRP2 7.8722 9.7647 6.2781 1.8252
NUGC-3 GDSC1; CTRP2 7.9614 10.4022 5.1797 1.3025
MKN1 GDSC1; CTRP2 8.0703 12.6144 5.0443 6.516
MKN7 GDSC1; GDSC2; CTRP2; CTRP1 8.1923 10.3569 5.3074 0.7548
IM95 GDSC1; CTRP2 8.6008 14.2988 4.6009 7.5048
SNU-216 CTRP2 9.1659 12.2299 5.9134 1.8163
SNU-668 CTRP2 9.1888 10.4866 6.6055 0.0995
SNU-719 CTRP2 9.1964 11.138 6.3729 0.4844
KATO III GDSC1; CTRP2 9.327 11.0399 6.462 0.2643
HuG1-N CTRP2 9.3418 11.0118 6.4778 0.2348
SNU-601 CTRP2 9.6768 16.4155 4.3108 7.1388
NUGC-4 GDSC1; CTRP2; CTRP1 9.9518 18.4837 3.5109 9.7513
KE-39 CTRP2 10.5974 18.9375 3.7153 8.1659
Fu97 GDSC1; CTRP2; CTRP1 12.4162 23.7279 2.6221 9.6963
SNU-1 GDSC1; CTRP2 12.5756 23.6563 2.7512 9.1079
LMSU CTRP2 15.5213 34.8514 -0.6081 15.0187
SNG-M GDSC1; CTRP1 6.5524 8.58 4.332 1.7136
SNU-685 CTRP2 8.1127 9.2023 5.6969 0.0544
SNU-1077 CTRP2 11.206 20.0187 3.5914 7.8706
⏷ Show the Full List of 44 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 18 Cell Line(s) in Thyroid Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
IHH-4 GDSC1 4.8074 6.6954 2.6533 1.7548
K5 GDSC1 5.151 6.7133 2.8024 0.6539
WRO GDSC1 5.2276 7.1477 2.6682 1.1689
ASH-3 GDSC1 5.6772 7.2118 2.826 0.2945
HTC-C3 GDSC1 5.7089 7.7474 2.6441 0.8527
KMH-2 GDSC1; GDSC2 5.7655 7.8121 2.6431 0.6547
FTC-238 CTRP2 5.8839 10.3925 4.3148 13.824
B-CPAP GDSC1; CTRP2 6.5616 7.2358 6.4486 3.494
FTC-133 GDSC1; CTRP2 7.7341 9.6115 5.395 0.7925
8305C GDSC1; CTRP2 8.2631 10.4698 6.1899 1.714
SW579 CTRP2 8.7816 15.7757 4.011 9.5647
8505C GDSC1; CTRP2 8.8003 21.5569 1.1784 19.3044
CAL-62 GDSC1; CTRP2 8.8499 9.9874 6.656 0.1
TT GDSC1; CTRP2 8.99 17.924 3.1117 12.637
BHT-101 GDSC1; CTRP2 9.0155 10.462 6.5503 0.2082
ML-1 [Human leukemia] GDSC1; GDSC2; CTRP2 9.8723 26.595 -0.5023 21.9532
TT2609-C02 GDSC1; CTRP2 10.2227 23.4265 1.3103 16.6502
CGTH-W-1 GDSC1; CTRP2 11.6541 23.2935 2.3471 11.4833
⏷ Show the Full List of 18 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 56 Cell Line(s) in Upper Aerodigestive Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
PCI-06A GDSC1; GDSC2 2.541 19.7692 -5.5612 37.3112
SCC-15 GDSC1 3.5177 12.9873 -1.3486 28.6342
HO-1-N-1 GDSC1 3.6331 5.5555 2.4527 5.8071
OSC-20 GDSC1 3.6358 6.5426 1.9651 9.5861
SAS GDSC1 4.5796 15.5281 -1.7673 26.7784
PCI-38 GDSC1 4.904 17.9372 -2.7127 28.7186
Ca9-22 GDSC1 4.9298 7.1612 2.5188 2.3694
LB771-HNC GDSC1 4.9851 8.0799 2.1445 4.6955
KOSC-2 GDSC1; GDSC2 5.0334 16.0765 -1.6913 22.3865
HO-1-u-1 GDSC1 5.1319 21.3321 -4.2228 31.6457
JHU-029 GDSC1; GDSC2 5.1587 7.7009 2.4074 2.1591
SCC-25 GDSC1; GDSC2 5.1999 13.4393 -0.2699 16.2624
PCI-15A GDSC1; GDSC2 5.2522 6.7877 2.8158 0.4295
DOK GDSC1 5.2799 33.4481 -10.1422 38.6731
BICR 10 GDSC1 5.3081 7.3992 2.605 1.3911
BB30-HNC GDSC1; GDSC2 5.4888 7.1491 2.777 0.4191
SKN-3 GDSC1 5.5939 22.0554 -4.2253 30.6013
BB49-HNC GDSC1 5.6868 7.701 2.6524 0.8372
KON GDSC1; GDSC2 5.9046 7.7922 2.7055 0.4163
UPCI-SCC-090 GDSC1 5.9135 7.6915 2.7448 0.403
HSC-2 GDSC1; CTRP2; CTRP1 6.2185 7.6443 5.9219 6.4803
OSC-19 GDSC1; GDSC2 6.2384 7.7253 2.8483 0.0906
NCI-H3118 GDSC1 6.4114 23.9393 -4.539 29.4923
HSC-3 GDSC1; CTRP2 6.4482 7.7343 5.5077 1.7028
BICR 78 GDSC1 6.5273 21.6261 -3.3157 26.4612
SAT [Human HNSCC] GDSC1 6.9124 17.8951 -1.2332 18.9504
PCI-04B GDSC1; GDSC2 6.9884 17.0696 -0.789 14.798
SCC-9 GDSC1; CTRP2; CTRP1 7.1149 8.3365 6.4661 2.389
JHU-022 GDSC1 7.3421 23.5577 -3.6728 25.6725
FaDu GDSC1; CTRP2 7.677 9.6623 6.2001 2.3874
BICR 6 CTRP2 7.7837 8.8338 5.7069 0.0887
Detroit 562 GDSC1; CTRP2 7.8771 10.6445 5.0324 1.8904
PCI-30 GDSC1 8.2251 22.0982 -2.3616 20.2516
SNU-899 CTRP2 8.3335 11.3576 5.8256 3.0028
JHU-011 GDSC1; GDSC2 8.4109 22.152 -2.2647 17.611
BICR 56 CTRP2 8.4546 10.1326 6.4366 0.7284
CAL-33 GDSC1; CTRP2 8.6196 25.4587 -0.9008 24.8664
SCC-4 GDSC1; CTRP2 8.8293 11.3296 6.1229 1.415
PE/CA-PJ49 CTRP2 8.9086 10.0331 6.6613 0.0848
SNU-1076 CTRP2 8.9529 24.0859 0.0412 22.115
BICR 18 CTRP2 8.9662 11.6749 6.0467 1.5486
BHY GDSC1; GDSC2; CTRP2 8.9855 10.5829 6.4944 0.3162
PE/CA-PJ41 (clone D2) CTRP2 9.041 10.3893 6.5857 0.1502
SNU-46 CTRP2 9.0821 13.8924 5.1146 4.8185
YD-10B CTRP2 9.1576 42.7126 -9.076 35.0358
BICR 31 GDSC2; CTRP2 9.2903 14.3654 5.0248 4.9057
PE/CA-PJ15 GDSC1; GDSC2; CTRP2 9.6776 11.3867 6.4705 0.1685
SNU-1214 CTRP2 9.8099 21.0584 2.17 14.61
BICR 16 CTRP2 10.729 21.9555 2.3733 12.6158
YD-8 CTRP2 11.1093 29.6794 -1.107 21.4997
SNU-1041 CTRP2 12.5678 27.0712 0.3425 12.8757
BICR 22 GDSC1; CTRP2 12.69 26.7732 1.3764 13.1358
SNU-1066 CTRP2 12.9601 27.832 0.2327 12.7288
HSC-4 GDSC1; CTRP2 13.0834 26.6022 1.7045 11.7252
PE/CA-PJ34 (clone C12) CTRP2 13.5026 28.6334 1.0217 13.1684
CAL-27 GDSC1; CTRP2 14.2581 44.2677 -5.9686 25.8608
⏷ Show the Full List of 56 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 25 Cell Line(s) in Urinary Tract Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
SW1710 GDSC1 4.456 6.9022 2.3655 4.2863
SW780 GDSC1 4.8246 11.2876 0.5114 15.8549
RT-112 GDSC1; CTRP2 5.1988 9.3714 3.6325 12.7656
647V GDSC1; CTRP2 5.9543 7.7372 5.6059 8.4323
HT-1197 GDSC1; CTRP2 6.7542 8.5787 6.0107 4.8184
UM-UC-3 GDSC1; CTRP2; CTRP1 7.232 9.1837 6.1111 3.4579
BC-3C CTRP2 7.5763 9.5618 6.1794 2.6164
T24 GDSC1; GDSC2; CTRP2 7.6597 9.4768 6.277 2.1035
U-BLC1 CTRP2 7.6659 9.2444 6.3909 1.6451
TCCSUP GDSC1; CTRP2 7.8507 14.3938 4.0022 11.1272
SCaBER CTRP2 8.6283 10.0952 6.5302 0.3856
639V GDSC1; CTRP2 8.6535 9.7893 6.6532 0.1443
KU-19-19 GDSC1; CTRP2 8.8453 10.1574 6.5945 0.1843
BFTC-905 GDSC1; CTRP2 8.9124 10.2469 6.588 0.1769
253J-BV CTRP2 8.9855 10.3361 6.5838 0.1653
253J CTRP2 9.0949 10.3825 6.6077 0.1124
5637 GDSC1; CTRP2; CTRP1 9.3602 11.8313 6.1746 0.8864
CAL-29 GDSC1; CTRP2 9.3724 10.7809 6.5699 0.1083
VM-CUB-1 CTRP2 9.4778 11.8925 6.2033 0.7477
HT-1376 GDSC1; CTRP2; CTRP1 9.5946 25.2257 -0.0346 21.2624
RT-4 GDSC1; CTRP2; CTRP1 9.6026 17.8943 3.5574 10.0715
J82 GDSC1; CTRP2 9.809 11.6357 6.4317 0.1914
JMSU-1 CTRP2 10.9055 19.907 3.4571 8.6996
UM-UC-1 CTRP2 11.2384 21.3853 2.9768 9.9388
KMBC-2 CTRP2; CTRP1 12.8569 24.4425 2.5607 9.3974
⏷ Show the Full List of 25 Cancer Drug Sensitivity Data of This Drug
Cancer Drug Sensitivity Data Curated from 38 Cell Line(s) in Urogenital System Tissue
Cell Line Original Dataset IC50 IC90 EC50 AUC
BPH-1 GDSC1 2.4447 19.5662 -5.5423 40.3167
NT2-D1 GDSC1 3.5823 5.8366 2.2744 7.3613
DoTc2 4510 GDSC1 3.7349 7.04 1.7949 10.5584
ME-180 GDSC1 3.9048 14.912 -1.9949 29.4891
SiHa GDSC1 3.9102 5.7883 2.5378 4.3496
PA-1 GDSC1 3.9877 7.1359 1.9373 8.6901
HT-3 GDSC1 4.0598 6.9789 2.0659 7.5083
SKG-IIIa GDSC1 4.3669 5.8908 2.7683 1.7354
SiSo GDSC1 4.5131 6.6245 2.5259 3.0533
C-33 A GDSC1 4.5797 6.6405 2.5565 2.7238
HEY GDSC1 4.7993 7.4897 2.3025 3.9998
NEC8 GDSC1 4.8782 7.2872 2.4368 2.9663
HEC-1 GDSC1 4.9017 6.6672 2.7106 1.3161
JEG-3 GDSC1; GDSC2 4.9409 6.3285 2.8603 0.4702
DSH1 GDSC1 4.9539 7.3585 2.4466 2.7754
OVCA420 GDSC1 5.0032 15.8213 -1.5879 24.9814
JHOS-3 GDSC1; GDSC2 5.1729 8.2822 2.1616 3.395
PWR-1E GDSC1 5.1876 12.573 0.1439 16.8857
JAR GDSC1; GDSC2 5.1916 7.294 2.5932 1.2724
CAL-39 GDSC1 5.2408 7.9641 2.3376 2.9819
TC-YIK GDSC1 5.3072 8.4126 2.1787 3.8625
KGN GDSC1 5.3541 7.3869 2.6306 1.2192
LB831-BLC GDSC1 5.4307 7.5393 2.6049 1.2633
SW756 GDSC1 5.4563 6.9708 2.8287 0.3809
Ca Ski GDSC1 5.4709 7.8212 2.5111 1.6818
SKN GDSC1 5.6733 17.0761 -1.7075 23.6436
OVMIU GDSC1 5.804 8.2851 2.4783 1.4845
C-4-I GDSC1 5.8301 7.4428 2.8012 0.2961
SW954 GDSC1; GDSC2 5.8302 14.0308 -0.1138 14.1495
OMC-1 [Human cervical carcinoma] GDSC1; GDSC2 5.8532 7.5094 2.7864 0.2588
PEO1 GDSC1 5.8617 7.5828 2.7638 0.3753
SW962 GDSC1; GDSC2 5.9345 7.5338 2.8074 0.199
UWB1.289 GDSC1; GDSC2 6.0522 9.5438 2.0839 2.6259
OVCA433 GDSC1; GDSC2 6.2536 8.2561 2.6721 0.3594
OV17R GDSC1; GDSC2 6.3588 8.2107 2.7263 0.2273
MS751 GDSC1 6.8172 17.258 -0.9925 18.1915
HeLa GDSC1; CTRP2 8.2006 9.3635 6.6277 0.3628
ACC-OV7 GDSC1; GDSC2 8.2019 26.2452 -4.3715 23.7038
⏷ Show the Full List of 38 Cancer Drug Sensitivity Data of This Drug

Drug-Drug Interaction (DDI) Information of This Drug

Coadministration of a Drug Treating the Same Disease as Tretinoin
DDI Drug Name DDI Drug ID Severity Mechanism Disease REF
Isotretinoin DM4QTBN Major Increased risk of pseudotumor cerebri by the combination of Tretinoin and Isotretinoin. Acne vulgaris [ED80] [18]
Sarecycline DMLZNIQ Major Increased risk of pseudotumor cerebri by the combination of Tretinoin and Sarecycline . Acne vulgaris [ED80] [19]
Coadministration of a Drug Treating the Disease Different from Tretinoin (Comorbidity)
DDI Drug Name DDI Drug ID Severity Mechanism Comorbidity REF
Remdesivir DMBFZ6L Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Remdesivir. 1D6YCoronavirus Disease 2019 [1D6YCoronavirus Disease 2019] [20]
Dronedarone DMA8FS5 Moderate Decreased metabolism of Tretinoin caused by Dronedarone mediated inhibition of CYP450 enzyme. Angina pectoris [BA40] [21]
Bedaquiline DM3906J Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Bedaquiline. Antimicrobial drug resistance [MG50-MG52] [22]
Posaconazole DMUL5EW Moderate Decreased metabolism of Tretinoin caused by Posaconazole mediated inhibition of CYP450 enzyme. Aspergillosis [1F20] [23]
Ofloxacin DM0VQN3 Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Ofloxacin. Bacterial infection [1A00-1C4Z] [24]
Clarithromycin DM4M1SG Moderate Decreased metabolism of Tretinoin caused by Clarithromycin mediated inhibition of CYP450 enzyme. Bacterial infection [1A00-1C4Z] [23]
Sparfloxacin DMB4HCT Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Sparfloxacin. Bacterial infection [1A00-1C4Z] [24]
Gemifloxacin DMHT34O Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Gemifloxacin. Bacterial infection [1A00-1C4Z] [24]
Norfloxacin DMIZ6W2 Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Norfloxacin. Bacterial infection [1A00-1C4Z] [24]
ABT-492 DMJFD2I Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by ABT-492. Bacterial infection [1A00-1C4Z] [24]
Omadacycline DMR2J95 Major Increased risk of pseudotumor cerebri by the combination of Tretinoin and Omadacycline. Bacterial infection [1A00-1C4Z] [19]
Levofloxacin DMS60RB Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Levofloxacin. Bacterial infection [1A00-1C4Z] [24]
Troleandomycin DMUZNIG Moderate Decreased metabolism of Tretinoin caused by Troleandomycin mediated inhibition of CYP450 enzyme. Bacterial infection [1A00-1C4Z] [23]
Minocycline DMVN5OH Major Increased risk of pseudotumor cerebri by the combination of Tretinoin and Minocycline. Bacterial infection [1A00-1C4Z] [19]
Lomefloxacin DMVRH9C Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Lomefloxacin. Bacterial infection [1A00-1C4Z] [24]
Telithromycin DMZ4P3A Moderate Decreased metabolism of Tretinoin caused by Telithromycin mediated inhibition of CYP450 enzyme. Bacterial infection [1A00-1C4Z] [23]
Tetracycline DMZA017 Major Increased risk of pseudotumor cerebri by the combination of Tretinoin and Tetracycline. Bacterial infection [1A00-1C4Z] [19]
Pexidartinib DMS2J0Z Major Increased risk of hepatotoxicity by the combination of Tretinoin and Pexidartinib. Bone/articular cartilage neoplasm [2F7B] [25]
Lapatinib DM3BH1Y Moderate Decreased metabolism of Tretinoin caused by Lapatinib mediated inhibition of CYP450 enzyme. Breast cancer [2C60-2C6Y] [26]
Tucatinib DMBESUA Moderate Decreased metabolism of Tretinoin caused by Tucatinib mediated inhibition of CYP450 enzyme. Breast cancer [2C60-2C6Y] [23]
Mifepristone DMGZQEF Moderate Decreased metabolism of Tretinoin caused by Mifepristone mediated inhibition of CYP450 enzyme. Cushing syndrome [5A70] [20]
Lumacaftor DMCLWDJ Moderate Increased metabolism of Tretinoin caused by Lumacaftor mediated induction of CYP450 enzyme. Cystic fibrosis [CA25] [27]
MK-8228 DMOB58Q Moderate Decreased metabolism of Tretinoin caused by MK-8228 mediated inhibition of CYP450 enzyme. Cytomegaloviral disease [1D82] [28]
Vilazodone DM4LECQ Moderate Decreased metabolism of Tretinoin caused by Vilazodone mediated inhibition of CYP450 enzyme. Depression [6A70-6A7Z] [29]
Nefazodone DM4ZS8M Moderate Decreased metabolism of Tretinoin caused by Nefazodone mediated inhibition of CYP450 enzyme. Depression [6A70-6A7Z] [23]
Oxcarbazepine DM5PU6O Moderate Increased metabolism of Tretinoin caused by Oxcarbazepine mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [30]
Cenobamate DM8KLU9 Moderate Increased metabolism of Tretinoin caused by Cenobamate mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [31]
Rufinamide DMWE60C Moderate Increased metabolism of Tretinoin caused by Rufinamide mediated induction of CYP450 enzyme. Epilepsy/seizure [8A61-8A6Z] [18]
Cannabidiol DM0659E Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Cannabidiol. Epileptic encephalopathy [8A62] [18]
Itraconazole DMCR1MV Major Decreased metabolism of Tretinoin caused by Itraconazole mediated inhibition of CYP450 enzyme. Fungal infection [1F29-1F2F] [23]
Ketoconazole DMPZI3Q Major Decreased metabolism of Tretinoin caused by Ketoconazole mediated inhibition of CYP450 enzyme. Fungal infection [1F29-1F2F] [23]
Ripretinib DM958QB Moderate Decreased metabolism of Tretinoin caused by Ripretinib mediated inhibition of CYP450 enzyme. Gastrointestinal stromal tumour [2B5B] [20]
Boceprevir DMBSHMF Moderate Decreased metabolism of Tretinoin caused by Boceprevir mediated inhibition of CYP450 enzyme. Hepatitis virus infection [1E50-1E51] [23]
Telaprevir DMMRV29 Moderate Decreased metabolism of Tretinoin caused by Telaprevir mediated inhibition of CYP450 enzyme. Hepatitis virus infection [1E50-1E51] [23]
Rifapentine DMCHV4I Moderate Increased metabolism of Tretinoin caused by Rifapentine mediated induction of CYP450 enzyme. HIV-infected patients with tuberculosis [1B10-1B14] [32]
Brentuximab vedotin DMWLC57 Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Brentuximab vedotin. Hodgkin lymphoma [2B30] [33]
Fosamprenavir DM4W9B3 Moderate Decreased metabolism of Tretinoin caused by Fosamprenavir mediated inhibition of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [23]
Cobicistat DM6L4H2 Moderate Decreased metabolism of Tretinoin caused by Cobicistat mediated inhibition of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [23]
Saquinavir DMG814N Moderate Decreased metabolism of Tretinoin caused by Saquinavir mediated inhibition of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [23]
Etravirine DMGV8QU Moderate Increased metabolism of Tretinoin caused by Etravirine mediated induction of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [34]
Darunavir DMN3GCH Moderate Decreased metabolism of Tretinoin caused by Darunavir mediated inhibition of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [35]
Atazanavir DMSYRBX Moderate Decreased metabolism of Tretinoin caused by Atazanavir mediated inhibition of CYP450 enzyme. Human immunodeficiency virus disease [1C60-1C62] [23]
Mipomersen DMGSRN1 Major Increased risk of hepatotoxicity by the combination of Tretinoin and Mipomersen. Hyper-lipoproteinaemia [5C80] [36]
Teriflunomide DMQ2FKJ Major Increased risk of hepatotoxicity by the combination of Tretinoin and Teriflunomide. Hyper-lipoproteinaemia [5C80] [37]
BMS-201038 DMQTAGO Major Increased risk of hepatotoxicity by the combination of Tretinoin and BMS-201038. Hyper-lipoproteinaemia [5C80] [38]
Conivaptan DM1V329 Moderate Decreased metabolism of Tretinoin caused by Conivaptan mediated inhibition of CYP450 enzyme. Hypo-osmolality/hyponatraemia [5C72] [23]
TP-434 DM5A31S Major Increased risk of pseudotumor cerebri by the combination of Tretinoin and TP-434. Infectious gastroenteritis/colitis [1A40] [19]
Berotralstat DMWA2DZ Moderate Decreased metabolism of Tretinoin caused by Berotralstat mediated inhibition of CYP450 enzyme. Innate/adaptive immunodeficiency [4A00] [39]
Brigatinib DM7W94S Moderate Increased metabolism of Tretinoin caused by Brigatinib mediated induction of CYP450 enzyme. Lung cancer [2C25] [40]
Ceritinib DMB920Z Moderate Decreased metabolism of Tretinoin caused by Ceritinib mediated inhibition of CYP450 enzyme. Lung cancer [2C25] [23]
PF-06463922 DMKM7EW Moderate Increased metabolism of Tretinoin caused by PF-06463922 mediated induction of CYP450 enzyme. Lung cancer [2C25] [41]
Selpercatinib DMZR15V Moderate Decreased metabolism of Tretinoin caused by Selpercatinib mediated inhibition of CYP450 enzyme. Lung cancer [2C25] [18]
Calaspargase pegol DMQZBXI Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Calaspargase pegol. Malignant haematopoietic neoplasm [2B33] [42]
Idelalisib DM602WT Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Idelalisib. Mature B-cell leukaemia [2A82] [43]
IPI-145 DMWA24P Moderate Decreased metabolism of Tretinoin caused by IPI-145 mediated inhibition of CYP450 enzyme. Mature B-cell leukaemia [2A82] [44]
Vemurafenib DM62UG5 Moderate Decreased metabolism of Tretinoin caused by Vemurafenib mediated inhibition of CYP450 enzyme. Melanoma [2C30] [20]
Dabrafenib DMX6OE3 Moderate Increased metabolism of Tretinoin caused by Dabrafenib mediated induction of CYP450 enzyme. Melanoma [2C30] [18]
Exjade DMHPRWG Moderate Decreased metabolism of Tretinoin caused by Exjade mediated inhibition of CYP450 enzyme. Mineral absorption/transport disorder [5C64] [45]
Fedratinib DM4ZBK6 Moderate Decreased metabolism of Tretinoin caused by Fedratinib mediated inhibition of CYP450 enzyme. Myeloproliferative neoplasm [2A20] [18]
Nilotinib DM7HXWT Moderate Decreased clearance of Tretinoin due to the transporter inhibition by Nilotinib. Myeloproliferative neoplasm [2A20] [46]
Dasatinib DMJV2EK Moderate Decreased metabolism of Tretinoin caused by Dasatinib mediated inhibition of CYP450 enzyme. Myeloproliferative neoplasm [2A20] [47]
Rucaparib DM9PVX8 Moderate Decreased metabolism of Tretinoin caused by Rucaparib mediated inhibition of CYP450 enzyme. Ovarian cancer [2C73] [48]
Abametapir DM2RX0I Moderate Decreased metabolism of Tretinoin caused by Abametapir mediated inhibition of CYP450 enzyme. Pediculosis [1G00] [49]
Lefamulin DME6G97 Moderate Decreased metabolism of Tretinoin caused by Lefamulin mediated inhibition of CYP450 enzyme. Pneumonia [CA40] [50]
Lonafarnib DMGM2Z6 Moderate Decreased metabolism of Tretinoin caused by Lonafarnib mediated inhibition of CYP450 enzyme. Premature ageing appearance [LD2B] [23]
ABIRATERONE DM8V75C Moderate Decreased metabolism of Tretinoin caused by ABIRATERONE mediated inhibition of CYP450 enzyme. Prostate cancer [2C82] [37]
Gatifloxacin DMSL679 Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Gatifloxacin. Respiratory infection [CA07-CA4Z] [24]
Leflunomide DMR8ONJ Major Increased risk of hepatotoxicity by the combination of Tretinoin and Leflunomide. Rheumatoid arthritis [FA20] [37]
Telotristat ethyl DMDIYFZ Moderate Increased metabolism of Tretinoin caused by Telotristat ethyl mediated induction of CYP450 enzyme. Small intestine developmental anomaly [DA90] [18]
Larotrectinib DM26CQR Moderate Decreased metabolism of Tretinoin caused by Larotrectinib mediated inhibition of CYP450 enzyme. Solid tumour/cancer [2A00-2F9Z] [20]
Trabectedin DMG3Y89 Moderate Increased risk of hepatotoxicity by the combination of Tretinoin and Trabectedin. Solid tumour/cancer [2A00-2F9Z] [18]
Armodafinil DMGB035 Minor Increased metabolism of Tretinoin caused by Armodafinil mediated induction of CYP450 enzyme. Solid tumour/cancer [2A00-2F9Z] [51]
LEE011 DMMX75K Moderate Decreased metabolism of Tretinoin caused by LEE011 mediated inhibition of CYP450 enzyme. Solid tumour/cancer [2A00-2F9Z] [52]
Fostamatinib DM6AUHV Moderate Decreased clearance of Tretinoin due to the transporter inhibition by Fostamatinib. Thrombocytopenia [3B64] [53]
Cinoxacin DM4EWNS Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Cinoxacin. Urinary tract infection [GC08] [24]
Nalidixic acid DMRM0JV Minor Decreased absorption of Tretinoin due to intestinal mucosa variation caused by Nalidixic acid. Urinary tract infection [GC08] [24]
⏷ Show the Full List of 76 DDI Information of This Drug

Drug Inactive Ingredient(s) (DIG) and Formulation(s) of This Drug

DIG
DIG Name DIG ID PubChem CID Functional Classification
Allura red AC dye E00338 33258 Colorant
Alpha-tocopherol E00243 14985 Antimicrobial preservative; Antioxidant
Ascorbyl palmitate E00581 54680660 Antioxidant
FD&C blue no. 1 E00263 19700 Colorant
FD&C blue no. 2 E00446 2723854 Colorant
Oleic acid E00421 445639 Emulsifying agent; Penetration agent; Solubilizing agent
Quinoline yellow WS E00309 24671 Colorant
Ammonia E00007 222 Alkalizing agent
Butylhydroxyanisole E00308 24667 Antimicrobial preservative; Antioxidant
Edetate disodium E00186 8759 Complexing agent
Eisenoxyd E00585 56841934 Colorant
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Ferrosoferric oxide E00231 14789 Colorant
Glycerin E00026 753 Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Hexahydric alcohol E00083 5780 Diluent; Flavoring agent; Humectant; Plasticizing agent
Medium-chain triglyceride E00640 Not Available Emollient; Lubricant; Surfactant
Nitrogen E00033 947 Aerosol propellant; Sparging agent
Polysorbate 80 E00665 Not Available Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Propylene glycol E00040 1030 Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Soybean lecithin E00637 Not Available Other agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Water E00035 962 Solvent
⏷ Show the Full List of 22 Pharmaceutical Excipients of This Drug
Pharmaceutical Formulation
Formulation Name Drug Dosage Dosage Form Route
Tretinoin 10 mg capsule 10 mg Oral Capsule Oral
Jump to Detail Pharmaceutical Formulation Page of This Drug

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2644).
2 Tretinoin FDA Label
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
4 BDDCS applied to over 900 drugs
5 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
6 Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose
7 Retinoids--which dermatological indications will benefit in the near future Skin Pharmacol Appl Skin Physiol. 2001 Sep-Oct;14(5):303-15.
8 Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. J Med Chem. 2004 Dec 30;47(27):6831-9.
9 Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters. Phytomedicine. 2012 Aug 15;19(11):977-87.
10 Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol. 2000 Dec;58(6):1341-8.
11 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
12 CYP26C1 is a hydroxylase of multiple active retinoids and interacts with cellular retinoic acid binding proteins. Mol Pharmacol. 2018 May;93(5):489-503.
13 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
14 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
15 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
16 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
17 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
18 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
19 Gardner K, Cox T, Digre KB "Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review." Neurology 45 (1995): 6-10. [PMID: 7824136]
20 Cerner Multum, Inc. "Australian Product Information.".
21 Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
22 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
23 Adamson PC "Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia." Semin Hematol 31 (1994): 14-7. [PMID: 7831580]
24 Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
25 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
26 Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
27 Cerner Multum, Inc. "Canadian Product Information.".
28 Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
29 Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
30 Product Information. Trileptal (oxcarbazepine) Novartis Pharmaceuticals, East Hanover, NJ.
31 Product Information. Xcopri (cenobamate). SK Life Science, Inc., Paramus, NJ.
32 Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
33 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
34 Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
35 Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
36 Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
37 Canadian Pharmacists Association.
38 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
39 Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
40 Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
41 Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
42 Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
43 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
44 Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
45 Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
46 Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
47 Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
48 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
49 Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
50 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
51 Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
52 DSouza DL, Levasseur LM, Nezamis J, Robbins DK, Simms L, Koch KM "Effect of alosetron on the pharmacokinetics of alprazolam." J Clin Pharmacol 41 (2001): 452-4. [PMID: 11304902]
53 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.